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Abstract 
The purpose of the present study was to identify the relations between nine dimensions of 
parents’ cognitive representations of ASD, their acceptance of their children’s ASD, and their 
treatment selection for their children with ASD.  Parents of children with ASD aged 21 years and 
younger (N = 124) completed an online survey, with 10 of those parents completing telephone 
follow-up interviews.  Logistic regression analyses revealed that stronger beliefs in personal 
control over one’s child’s ASD were associated with selection of medication-based treatments, 
while stronger beliefs in external causes of ASD were associated with selection of metabolic 
treatments.  Correlation analyses also revealed that lower levels of acceptance were associated 
with selecting greater numbers of treatments, regardless of empirical support. Results suggest 
that programs aiming to increase parents’ acceptance and teach parents to be more “research 
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Introduction 
What is ASD? 
Autism Spectrum Disorders (ASD) are a group of neurodevelopmental disorders 
associated with impairments in communication and social interest, and the presence of 
stereotyped or repetitive behaviours (American Psychiatric Association [APA], 2000).   
Although Leo Kanner first identified what he called “autistic disturbances of affective contact” 
in 1943, it is only in recent decades that the general public has learned of ASD, primarily 
through films such as Rainman and Mercury Rising, and recent media coverage highlighting 
parents of children with ASD, such as celebrity mother Jenny McCarthy (Jones & Harwood, 
2009).  This dramatic increase in public knowledge of ASD has been accompanied by a dramatic 
increase in the number of children diagnosed with ASD each year (Chakrabarti & Fombonne, 
2005; Prior, 2003).  Presently, it is estimated that approximately 1 in 88 children have ASD 
(Centers for Disease Control and Prevention [CDC], 2012).   
With ASD increasingly becoming a topic of public interest, the number of proposed 
treatments for ASD has also increased (National Autism Center [NAC], 2009), with some even 
claiming to offer a “cure” for children’s ASD without providing empirical support for this claim 
(e.g., McCarthy, 2007).  Unfortunately, upon learning that their children have ASD, parents are 
often emotionally overwhelmed and vulnerable to believing these unsupported claims (Seigel, 
1997).  For this reason, parents’ treatment selection for their children with ASD is of particular 
interest to researchers studying methods of improving access to evidence-based services among 
children with ASD.  
Receiving a Diagnosis of ASD  
For most parents of children with ASD, receiving the diagnosis of ASD leads them to  
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experience mixed emotions (Gray, 1993; Mansell & Morris, 2004; O’Brien & Daggett, 2006; 
Siegel, 1997).  Many parents have had to wait several months for diagnosis and experience a 
sense of relief and validation that their suspicions have finally been verified (Mansell & Morris, 
2004; Midence & O’Neil, 1999; Sullivan, 1997; Wachtell & Cater, 2008).  Often simultaneously, 
however, many parents experience shock, disbelief, and a deep sense of loss upon receiving the 
diagnosis (Avdi, Griffin, & Brough, 2000; Midence and O’Neill, 1999; O’Brien & Daggett, 
2006; Piper & Howlin, 1992; Wachtell & Carter, 2008).  It appears that, although parents have 
likely been concerned about their children’s development for several months and may have even 
suspected that their children would be diagnosed with ASD, they commonly come to the 
assessment appointment hoping that their suspicions will not be confirmed (Gray, 1993).   
In addition to the initial shock, parents often experience emotional strain because they 
feel they have not properly protected their children, or that they may have somehow inflicted 
ASD on their children; they worry about their children’s future independence and realize that 
they must redefine their relationship with their children to accommodate this new information 
(O’Brien & Daggett, 2006).  Particularly because their children do not differ in physical 
appearance from children with typical development, parents often struggle with reconciling their 
“post-diagnosis” child and their “pre-diagnosis” child (Mansell & Morris, 2004; O’Brien & 
Daggett, 2006).  As such, many parents go through a phase of grieving for “the children that 
could have been”, similar to the grieving process of parents who have experienced the deaths of 
their children (Mansell & Morris, 2004; Wachtell & Carter, 2008).   
This process of grieving has been described as a complex experience involving shock,  
denial, guilt, isolation, panic, anger, bargaining, acceptance, and hope (Valman, 1981, as cited in 
Shapiro, 1983), with parents continuously cycling between periods of sadness, acceptance, and 
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stress at various points in their children’s development (Tunali & Power, 1993).  One parent of a 
child with ASD aptly described her experience within this cycle as the following: “Initial Shock 
– Denial, Anger, Disbelief, Why us? Why him? Why? – Acceptance – Anger to do something to 
help him/us. Tired, frustrated, sometimes calm-ish! Always on the go, worry. A yo-yo!” 
(Mansell & Morris, 2004, p. 404).   
Although the stages of grieving experienced by parents after learning that their children 
have ASD share many similarities with the stages of grieving experienced by parents after the 
deaths of children, there are several important distinctions.  First, when parents experience the 
deaths of children, members of their primary support system often share their grief and act as 
significant sources of comfort.  When children are diagnosed with ASD, however, many parents 
experience feelings of isolation from members of their primary support system, who are often 
unaware of the child’s diagnosis or avoid the parents because they may be unsure about how to 
behave around them.  As Sullivan (1997) described: 
The news of your child’s autism does not get announced in the local paper.  There is no 
gathering of family and friends at which your pastor solemnly announces the diagnosis.  
The news sits heavily on your shoulders, and it’s up to you to decide how and when, or 
even if, you announce it. (p. 1010). 
Additionally, the grieving process for parents of children with ASD occurs at the same 
time as they are being asked to make important decisions regarding their child’s treatment and to 
plan for their child’s future (O’Brien & Daggett, 2006).  These almost contradictory demands 
placed on parents may serve to complicate their emotions, leading them to feel grief and hope 
simultaneously.  Boss (1999) termed this experience “ambiguous loss” and asserted that it often 
leads parents to fail to adapt their family roles and routines to accommodate their child with 
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ASD, repress their feelings of grief and mourning, question their beliefs and value systems, 
experience exhaustion, and have difficulty making thoughtful decisions on behalf of their 
children.    
Accepting the Diagnosis of ASD 
With the complicated emotional reactions many parents experience in response to their 
child’s diagnosis of ASD, it is understandable that the process of coming to accept their child’s 
diagnosis is often quite difficult for parents.  In relation to ASD, acceptance is often described as 
involving two components: (a) recognizing the children’s realistic limitations and (b) 
maintaining awareness that significant improvement can occur with intervention (Mansell & 
Morris, 2004).  In this sense, it should be noted that accepting children’s diagnoses of ASD does 
not mean believing that the children cannot improve and, therefore, not seeking interventions to 
help the children achieve their full potential.  In fact, an important component of acceptance is 
the realization that vast improvement is possible with high quality intervention.     
Despite previous beliefs that parents’ acceptance of their children’s developmental 
disabilities improves over time, it has been demonstrated that parents tend to cycle between 
phases of despair and acceptance at various stages of their children’s development (Milshtein, 
Yirmiya, Oppenheim, Koren-Karie, & Levi, 2010).  Furthermore, it has been shown that, on 
average, parents of children with ASD report significantly lower levels of acceptance of their 
children’s disabilities than do parents of children with other developmental disabilities such as 
Down Syndrome (Zembat & Yildiz, 2010).  One recent study demonstrated that two-thirds of 
mothers and one-half of fathers of children with ASD had not resolved (i.e., did not accept) their 
child’s diagnosis (Milshtein, Yirmiya, Oppenheim, Koren-Karie, & Levi, 2010).  Although only 
a minority of parents of children with ASD achieve full acceptance of their child’s diagnosis, 
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parents who have achieved this acceptance often report that coming to terms with their child’s 
diagnosis of ASD was an integral and “life changing” step in their journeys to help their children 
(Midence & O’Neil, 1999; O’Brien & Daggett, 2006).   
Through analyzing in-depth interviews with several parents of children with ASD, Pianta, 
Marvin, Britner, and Borowitz (1996) asserted that parents who had achieved acceptance of the 
diagnosis of ASD were able to acknowledge the positive and negative consequences of the 
diagnosis, did not obsess about the causes of their children’s ASD, and demonstrated realistic 
understandings of their children’s abilities and challenges.  In contrast, parents who had not 
achieved acceptance of the diagnosis demonstrated confusion regarding several aspects of the 
diagnosis, held unbalanced views of the consequences of the diagnosis (i.e., all negative or all 
positive), lacked energy and motivation, maintained unrealistic beliefs regarding their children’s 
abilities and challenges, and often appeared detached from their emotions in relation to the 
diagnosis.   
Selecting Treatments for a Child with ASD 
Parents are also faced with the task of selecting treatments for their children, in addition 
to struggling to accept the diagnosis.  This is an additional task put on parents immediately upon, 
or sometimes prior to, receiving the diagnosis.  Parents often view it as overwhelming to sort 
through a bewildering number of proposed treatments of unequal effectiveness (e.g., Francis, 
2005; NAC, 2009; Valentine, 2010). 
Importance of early, evidence-based intervention.  It is now widely accepted that early 
intervention (i.e., intervention beginning before the age of four) is associated with the most 
positive outcomes for children with ASD overall (e.g., Miriam Foundation, 2008; Children’s 
Mental Health Ontario, 2003; Rogers, 1996).  Although early intervention is important for 
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children with many types of disabilities (Ramey & Ramey, 1998), it may be particularly 
important for children with ASD as previous studies have demonstrated that young children with 
ASD make significantly more gains through intervention than young children with other 
developmental disabilities such as Cerebral Palsy (Guralnick, 2005; Rogers, 1996).  This finding 
may point to a somewhat unique neuroplasticity in young children with ASD, highlighting the 
need for intervention during this “critical period” of neurodevelopment (Dawson, 2008; Rogers, 
1996).   
With the known benefits of early intervention, many parents of children with ASD feel 
pressure to select treatments for their children as soon as possible, often without support from 
professionals (Hillman, 2006; Lilley, 2011; Valentine, 2010; Wachtell & Carter, 2008).  
Unfortunately, this pressure to decide quickly often leaves parents vulnerable to the claims of 
many empirically unsupported treatments that the treatments are effective or even offer a cure for 
ASD (Francis, 2005).  Although there is presently no cure for ASD (Howlin & Moore, 1997; 
Roberts, 2004), parents often maintain hope that the ASD will one day disappear (e.g., Danta, 
2006).  Accordingly, parents often try empirically unsupported treatments with their children 
(alone or in combination with other treatments) in the hopes of miracle recovery (Christon, 
Mackintosh, & Myers, 2010; Mandell & Novak, 2005).  Parents often feel that there is no harm 
in trying empirically unsupported treatments with their children.  However, this approach risks 
wasting the time, energy, and financial resources of children with ASD and their families 
(Children’s Mental Health Ontario, 2003). 
Additionally, many empirically unsupported treatments for ASD have been associated 
with serious side effects.  For example, there is a lack of empirical support for medication-based 
treatments (used independently) for ASD (Children’s Mental Health Ontario, 2003).  Although 
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some medication-based treatments such as Haloperidol, Risperidone, and Clomipramine have 
been associated with reductions in aggression, self injury, and stereotyped behaviour in 
individuals with ASD, they have also been associated with harmful side effects such as sedation, 
seizures, and dyskinesias (Children’s Mental Health Ontario, 2003).  The gluten/casein-free diet, 
touted as a “miracle cure” by celebrity mother Jenny McCarthy (e.g., McCarthy & Kartzinel, 
2009), has also been found to be associated with potential medically harmful side effects such as 
deficiencies in essential amino acids and suboptimal bone development (Arnold, Hyman, 
Mooney, & Kirby, 2003; Heiger, England, Molloy, Yu, Manning-Courtney, & Mills, 2008; 
Mulloy, Lang, O’Reilly, Sigafoos, Lancioni, & Rispoli, 2009).  Similarly, although facilitated 
communication received significant media attention as a key which may unlock the thoughts and 
emotions of individuals with ASD, it has been widely discredited due to empirical evidence that 
it is most often the thoughts and emotions of treatment facilitators, not individuals with ASD, 
being communicated (Perry, Bryson, & Bebko, 1998).  As such, this treatment is associated with 
many serious risks, including emotional distress to individuals with ASD and their families 
(Children’s Mental Health Ontario, 2003).   
What is known about parents’ treatment selection.  Despite the demonstrated benefits 
of early, evidence-based intervention and the risks of empirically unsupported treatments, 
empirical support is often not the most influential factor in parents’ treatment selection for their 
children with ASD.  As one study demonstrated, the four treatments parents most frequently 
reported selecting for their children with ASD (i.e., speech therapy, visual schedules, sensory 
integration, and applied behavior analysis, respectively) varied significantly in terms of empirical 
support (Green et al., 2006).  Similarly, Wong and Smith (2006) found that 52% of parents of 
children with ASD report having used complementary or alternative (i.e., empirically 
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unsupported) treatments with their children, compared to only 28% of parents of children with 
typical development.   
The mounting evidence that empirical support is not the most influential factor in parents’ 
treatment selection for their children with ASD has left many clinicians and researchers 
wondering which factors are most important in these parents’ treatment selection.  Despite the 
importance of this question, relatively few empirical studies have been conducted on the topic 
and the findings are inconsistent.  Callahan, Henson, and Cowan (2008) found that parents’ 
treatment selection for their children with ASD was significantly influenced by the social 
validation of the proposed treatments (i.e., the social acceptability of the goals, procedures, and 
outcomes).  This finding may be helpful in understanding why some parents continue to select 
facilitated communication as a treatment for their children with ASD, despite its demonstrated 
ineffectiveness.     
There is presently conflicting evidence regarding the influence of children’s 
characteristics on parents’ treatment selection.  For example, Goin-Kochel et al. (2007) found 
that younger children with ASD were more likely to receive behavioural treatments and older 
children with ASD were more likely to receive psychopharmacological treatments.  Conversely, 
however, a more recent study found no associations between children’s ages and the types of 
treatments selected by parents (Dardennes, Al Anbar, Prado-Netto, Kaye, Contejean, & Al 
Anbar, 2011).  In addition, although Goin-Kochel et al. (2007) found that children diagnosed 
with Asperger’s Disorder were more likely to receive psychopharmacological treatments than 
children diagnosed with Autistic Disorder or Pervasive Developmental Disorder Not Otherwise 
Specified, Dardennes et al. (2011) did not find a relation between the severity of children’s ASD 
symptomology and the types of treatments selected by their parents.   
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These conflicting findings may be better understood by considering methodological 
differences between the two studies.  For example, Goin-Kochel et al. (2007) used a primarily 
American sample of parents (i.e., 77.5% American), while Dardennes et al. (2011) used a sample 
of parents from France.  The healthcare funding of various ASD treatments varies widely 
between these two countries and likely acts as a confounding variable in comparisons between 
these studies.  In addition, the children of interest in the study by Dardennes et al. (2011) (mean 
age = 13.5 years) were much older than the children of interest in the study by Goin-Kochel et al. 
(2007) (mean age = 8.3 years).  This age difference between the children from each study likely 
acts as another confounding variable which must be considered.   
Culture may also affect parents’ treatment selection for their children with ASD.  One 
study found that Latino parents of children with ASD living in Philadelphia were six times more 
likely than parents of children with ASD from other cultural groups to select non evidence-based 
treatments for their children (Levy, Mandell, Merhar, Ittenback, & Pinto-Martin, 2003).  
Similarly, Mandell and Novak (2005) argued that the interaction between the cultural 
backgrounds of parents of children with ASD and the resources available in the community may 
influence parents’ treatment selection.   
Parents’ beliefs about the causes of their children’s ASD have also been shown to affect 
their treatment selection.  For example, Dardennes et al. (2011) found that parents who blame 
early traumatic experiences for their children’s ASD were less likely to select behaviour-based 
therapies and the Picture Exchange Communication System (PECS), whereas parents who 
attributed cause to an illness during pregnancy were more likely to select psychopharmacological 
treatments.  Additionally, parents who believed their children’s ASD to be caused by food 
allergies were more likely to select detoxification, special diets, and vitamin-based treatments 
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and less likely to select psychopharmacological treatments for their children.  Finally, parents 
who believed that brain abnormalities were a causal factor in their children’s ASD were less 
likely to select vitamin-based treatments for their children.   
In another study, these researchers also found that parents who held external causal 
attributions (i.e., believed in environmental causes) were more likely to select special diets and 
vitamin-based treatments (Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean, 2010).  In 
Taiwan, Shyu, Tsai, & Tsai, (2010) found  that parents who perceived food allergies as having 
caused their children’s ASD were more likely to avoid certain food products, while parents who 
believed in supernatural causes of their children’s ASD were more likely to try strategies such as 
consulting fortune tellers, changing the children’s names, and praying. 
Taken together, these findings demonstrate that parents’ treatment selection appears to be 
influenced by several interconnected factors, rather than by any one factor alone.  A qualitative 
study in Taiwan concluded that parents’ treatment selection is influenced by their causal 
attributions, perceived treatment effects, children’s preferences, and the fit of the children and 
parents with the treatment providers (Shyu, Tsai, & Tsai, 2010).  Similarly, Mandell and Novak 
(2005) asserted that parents’ perceptions and interpretations of the symptoms of ASD, their 
beliefs about the causes and course of the disorder, and their past experiences with healthcare 
providers all contribute significantly to parents’ treatment selection for their children with ASD.   
Self-regulation model of illness behaviour.  A theoretical model which has recently been 
applied to the study of parents’ treatment selection for their children with ASD is Leventhal’s 
self-regulation model of illness behaviour (Leventhal, Leventhal, & Contrada, 1999; Leventhal, 
Meyer, & Nerenz, 1980).  This model proposes that individuals form “common sense” cognitive 
representations of their illnesses.  These cognitive representations consist of individuals’ 
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judgments regarding five dimensions: (a) identity, (b) cause, (c) consequences, (d) timeline, and 
(e) control/cure.  The identity dimension includes both the individual’s label for the health threat 
(e.g., ASD, diabetes) and the symptoms the individual associates with the threat (e.g., difficulty 
communicating, fatigue).  The cause dimension represents the individual’s beliefs about the 
causes of the health threat (e.g., vaccines, sedentary lifestyle).  The consequences dimension 
includes both the imagined and real ways in which the individual’s life has been affected by the 
health threat (e.g., social isolation, loss of work time).  The timeline dimension includes the 
individual’s beliefs regarding the length of time over which the health threat developed, the 
duration of the health threat, and the length of time necessary for recovery.  Finally, the 
control/cure dimension of the model represents the extent to which the individual believes the 
health threat can be controlled, kept from progressing, and cured.   
These five dimensions of illness representations help individuals to formulate an 
understanding of the various aspects of their illnesses and enable them to plan their next steps in 
response to their health threats.  Based on these cognitive representations, individuals select 
coping strategies to use in response to various difficulties associated with their illnesses 
(Leventhal, Leventhal, & Contrada, 1999; Leventhal, Meyer, & Nerenz, 1980).  Additionally, 
individuals’ cognitive representations of their illnesses have been demonstrated to predict their 
psychological wellbeing (Hagger & Orbell, 2003) and medication adherence (Brewer, Chapman, 
Brownlee, & Leventhal, 2002).   
Although Leventhal’s model (Leventhal, Leventhal, & Contrada, 1999; Leventhal, 
Meyer, & Nerenz, 1980) was originally intended to be applied to individuals’ cognitive 
representations of their own illnesses, Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean 
(2010) in France have recently applied the model to study parents’ cognitive representations of 
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ASD.  They aimed to explore the associations between the treatment selection of parents of 
children with ASD and the illness perceptions of those parents.  In this study, 89 participants 
completed the Revised Illness Perception Questionnaire (IPQ-R; Moss-Morris et al., 2002) 
modified for ASD, which measured the five dimensions of parents’ cognitive representations of 
their children’s ASD (i.e., illness representations).  Participants also completed a demographic 
questionnaire and indicated which treatments they were currently using or providing for their 
children. 
Al Anbar et al. (2010) found that parents’ cognitive representations of ASD were 
associated with their treatment selection for their children in several specific ways.  Parents who 
viewed ASD as having more serious consequences for themselves and their children were more 
likely to select what the researchers termed “educative treatments” (i.e., behaviour therapy, 
social skills therapy, Treatment and Education of Autistic and Communication-related 
handicapped Children [TEACH], and the Picture Exchange Communication System [PECS]; p. 
821).  Parents who held stronger beliefs in a cyclical timeline of ASD were more likely to select 
psychopharmacological treatments for their children.  Parents who held stronger beliefs in their 
ability to control their children’s ASD were also less likely to select metabolic treatments, such 
as special diets and vitamin regimens, and psychopharmacological treatments for their children.  
Parents who had more negative emotional reactions to the diagnosis of ASD were also less likely 
to select behavioural treatments for their children.  The researchers found even stronger relations 
between parents’ causal beliefs about ASD and their treatment selection for their children.  
Specifically, parents who had stronger external causal attributions for their children’s ASD (i.e., 
believed their children’s ASD was caused by environmental factors) were more likely to select 
metabolic treatments such as special diets and vitamin regimens for their children.   
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Although this study was pioneering in its exploration of the relations between parents’ 
cognitive representations of ASD and their treatment selection for their children, it had some 
limitations.  First, participants were given only a “short list of treatments” to indicate “those they 
were using or providing for their child” (Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean, 
2010, p. 820).  Using this list of treatments in the study likely hindered the identification of 
treatments not listed.  Additionally, parents were instructed to indicate only which treatments 
they were presently using or providing for their children, thus not accounting for previous and 
anticipated (i.e., waitlisted) treatments.   
Another limitation of this study was that, although the researchers modified the identity 
scale of the IPQ-R (Moss-Morris et al., 2002) to include ASD-specific symptoms, they drew 
their items from the diagnostic criteria outlined in the Diagnostic and Statistical Manual of 
Mental Disorders-III- Revised (APA, 1987), which is now outdated.  Finally, the researchers left 
the original, general causes of health concerns (e.g., stress, aging, alcohol) items on the Causes 
subscale of the IPQ-R (Moss-Morris et al., 2002), and did not add causes often believed to be 
associated with ASD (e.g., vaccines, food allergies).  Therefore, this measure may not have been 
a valid indication of parents’ causal attributions in relation to their children’s ASD. 
The Present Study 
The present study empirically investigated the relations between parents’ cognitive 
representations and their treatment selection for their children with ASD, as an extension of the 
exploratory work of Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010).  The 
limitations of the previous study were addressed by modifying the IPQ-R (Moss-Morris et al., 
2002) to include ASD-specific symptoms as outlined in the DSM-IV-TR (APA, 2000), an 
expanded list of treatments which allowed parents to indicate those they were currently using 
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with their children as well as past and planned treatments, and a list of ASD-specific causes.  In 
addition, the present study included a measure of social desirability in order to control for this 
potentially confounding variable in all analyses.  Since associations between parents’ cognitive 
representations of their children’s ASD and their treatment selection have only recently begun to 
be studied, the present study also incorporated several exploratory open-ended questions for 
qualitative analysis. 
As the present study aimed to investigate parents’ treatment selection for their children 
with ASD, a participatory action research (PAR) framework was utilized to ensure that the goals, 
methods, results, and conclusions of the study were relevant, responsible, and helpful to parents 
of children with ASD.  PAR is a model of conducting research wherein individuals from the 
population of interest (e.g., parents of children with ASD) act as active collaborators in the 
research process, rather than passive objects of others’ examination (Whyte, Greenwood, & 
Lazes, 1989).  Although this philosophy of research is applicable to all researchers working with 
living participants, it is believed to be particularly valuable in better understanding and 
improving health service delivery to individuals from minority backgrounds (McAllister, Green, 
Terry, Herman, & Mulvey, 2003).  Within the present study, two mothers of children with ASD 
acted as important collaborators (i.e., Parent Advisors) in the research process.  These Parent 
Advisors were seen as well-qualified for the position as, in addition to each having a child with 
ASD, they are both employed in the ASD field, actively involved in the local ASD community, 
and are frequently sought out by other parents of children with ASD in the community for 
advice.   
The original Parent Advisor for the present study helped select the topic of investigation 
based on her own experiences and challenges in selecting treatments for her child with ASD, and 
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helped to select and refine the measures to ensure that they were accessible and relevant to 
parents.  She also had an active role in recruiting other parents of children with ASD to 
participate in the study.  The second Parent Advisor participated in analyzing and interpreting the 
obtained results from the study.   
As noted by McAllister, Green, Terry, Herman, and Mulvey (2003), including individuals 
from the population of interest as coinvestigators in public health-related research is not only a 
matter of respect, but also improves the ability of researchers to identify, understand, and 
effectively address key public health issues.  As such, it is believed that this collaboration with 
Parent Advisors in the present study helped to ensure that all aspects of the study addressed 
concerns relevant to parents of children with ASD through methods that were likely to yield the 
most useful results for individuals with ASD and their families.     
An additional contribution of the present study is that it was one of the first studies to 
examine parents’ acceptance of their children’s ASD and its associations with their treatment 
selection for their children.  Although these associations had not been specifically studied in the 
past, previous research was interpreted to indicate that specific relations were expected.  For 
example, it has been shown that parents with higher levels of acceptance of their children’s ASD 
have more realistic understandings of the abilities and limitations of their children (Pianta, 
Marvin, Britner, & Borowitz, 1996).  This finding was interpreted to indicate that parents with 
higher levels of acceptance of their children’s ASD may be less likely to select non evidence-
based treatments promising a “miracle cure” for their children.  Boss (1999) has also asserted 
that parents who are still struggling with ambiguous loss and who, therefore, maintain low levels 
of acceptance of their children’s ASD often have difficulty making thoughtful decisions on 
behalf of their children.  This finding was interpreted to indicate that parents with lower levels of 
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acceptance of their children’s ASD may be more susceptible to the claims of non evidence-based 
treatments and may be more likely to select these treatments for their children.   
Several other researchers have conjectured about the relations between parents’ 
acceptance of their children’s ASD and their treatment selection.  For example, in 1997, Siegel 
hypothesized that “Parents who are unable to accept their child’s autism… are susceptible to 
quick fixes for autism or other treatments not supported by empirical data” (p. 758).  Here again 
it was hypothesized that parents with lower levels of acceptance of their children’s ASD will be 
more likely to select non evidence-based treatments for their children.  Similarly, Mandell and 
Novak (2005) hypothesized that:  
Families that believe autism is a curable condition may follow a treatment regimen 
designed to cure the disorder… Families that believe autism is a chronic condition whose 
symptoms and related disability may be alleviated but not cured may make different, 
perhaps more stable, treatment decisions. (p. 112)   
Most recently, a more specific hypothesis regarding the relation between parents’ 
acceptance of their children’s ASD and their treatment selection has been articulated.  When 
discussing the results of their study of the effects of acceptance on the wellbeing of fathers of 
children with intellectual disabilities, MacDonald, Hastings, and Fitzsimons (2010) mentioned 
that: 
One would hypothesize that parents better able to stay with difficult emotions [i.e., 
parents with higher levels of acceptance] will be more likely to implement behaviour 
management techniques that may initially lead to increased occurrence of aversive  
behaviour problems or simply require parents to actively engage with their children.  
(p. 35).    
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This hypothesis suggests that parents with higher levels of acceptance of their children’s ASD 
may be more likely to select evidence-based behavioural treatments for their children with ASD.   
The purpose of the present study was to identify the relations between parents’ cognitive 
representations of their children’s ASD, acceptance of their children’s ASD, and treatment 
selection for their children with ASD.  It was believed that, if associations were found, this 
would have implications for clinicians working with parents during initial diagnosis and 
afterwards, particularly since both acceptance and cognitive representations have been 
demonstrated to be amenable to change through intervention (Blackledge & Hayes, 2006; Petrie, 
Chapman, Ellis, Buick, and Weinman, 2002).   
Hypotheses 
Hypotheses of the present study were based on both the findings of previous studies and 
on untested hypotheses previously offered by researchers studying ASD.  
Hypothesis I: Cognitive representations of ASD. 
1a: Belief in consequences. It was predicted that parents with cognitive representations 
of ASD which include higher beliefs in the severity of ASD and its impact on various aspects of 
their children’s functioning (i.e., higher scores on Consequences subscale of the IPQ-RA-E) 
would be more likely to select behavioural treatments for their children (e.g., Al Anbar, 
Dardennes, Prado-Netto, Kaye, & Contejean, 2010). 
1b: Belief in timeline.  It was predicted that parents with cognitive representations of 
ASD which include higher beliefs in a cyclical course of ASD symptomology (i.e., higher scores 
on the Timeline [Cyclical] subscale of the IPQ-RA-E) would be more likely to select medication-
based treatments for their children (e.g., Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean, 
2010).   
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1c: Belief in control. It was predicted that parents with cognitive representations of ASD 
which include higher beliefs in personal control over ASD (i.e., higher scores on the Personal 
Control subscale of the IPQ-RA-E) would be less likely to select medication-based, special diets, 
and vitamin-based treatments for their children (e.g., Al Anbar, Dardennes, Prado-Netto, Kaye, 
& Contejean, 2010).   
1d: External causal beliefs.  It was predicted that parents with cognitive representations 
of ASD which include higher beliefs in external causes (e.g., pollution, diet, germ or virus, poor 
medical care in the past) of their children’s ASD would be more likely to select special diets and 
vitamin-based treatments for their children (e.g., Al Anbar, Dardennes, Prado-Netto, Kaye, & 
Contejean, 2010).   
1e: Emotional representations.  It was predicted that parents with more negative 
emotional reactions to the diagnosis of ASD (i.e., higher scores on the Emotional 
Representations subscale of the IPQ-RA-E) would be less likely to select behavioural treatments 
for their children (e.g., Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean, 2010).   
Hypothesis II: Acceptance of children’s ASD. 
2a: High acceptance of ASD.  It was predicted that parents with higher levels of 
acceptance of their children’s ASD (i.e., lower scores on the AAQ-II-A) would be more likely to 
select evidence-based treatments for their children (MacDonald, Hastings, & Fitzsimons, 2010; 
Mandell & Novak, 2005; Siegel, 1997). 
2b: Low acceptance of ASD.  It was predicted that parents with lower levels of 
acceptance of their children’s ASD (i.e., higher scores on the AAQ-II-A) would be more likely to 
select non evidence-based treatments for their children (e.g., MacDonald, Hastings, & 
Fitzsimons, 2010; Mandell & Novak, 2005; Siegel, 1997). 
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Exploratory.  Factors influencing parents’ cognitive representations of ASD and their 
acceptance of their children’s ASD were also explored.   
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Method 
Participants 
Respondents.  Participants were 124 parents of children with ASD.  In order to 
maximize recruitment of participants, no restrictions were placed on the gender of the parent or 
the geographic location of the parent in the current study.  Participants were recruited by handing 
out flyers and speaking with parents at parenting and disability-related events in Ontario through 
organizations such as: the Summit Centre for Preschool Children with Autism, the Windsor-
Essex Chapter of Autism Ontario, St. Mary’s Family Learning Centre, and Autism Services 
Incorporated of Windsor and Essex County.  In addition, participants were recruited through 
advertisements on several online forums and emails sent through parent organizations.  For a 
complete list of the ASD-related organizations and listservs through which parents were 
recruited, please see Appendix A. 
The majority of participants (91.1%) were mothers, White (79.8%), and identified 
themselves as being married or in common-law relationships (80.6%).  49.2% were in the 35 to 
44 year age range.  Most participants reported having graduated from college or university 
(75.8%) and, although many reported having an annual household income of $75 000 and over 
(46%), a substantial portion (21.8%) reported having an annual household income of $25 000 to 
$49 999.  Most participants were from the United States (45.2%) or Canada (25%); however, 
Australia, India, Indonesia, Singapore, and the United Kingdom were also represented in the 
sample.  For more information regarding the demographic characteristics of participants, please 
see Table 1.   
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Table 1 
Respondent Demographic Information 
 
 
 Variable Number (%) 
   Race/Ethnicity (N = 124) 
  Black 2 1.6 
Chinese 6 4.8 
Filipino 3 2.4 
Latin American 2 1.6 
South Asian (East Indian, Pakistani, Sri Lankan, etc.) 3 2.4 
Southeast Asian (Cambodian, Indonesian, Laotian, Vietnamese,  
   etc.) 2 1.6 
White 99 79.8 
Other  6 4.8 
   Gender (N = 124) 
  Male 10 8.1 
Female 113 91.1 
   Age (N = 124) 
  18 - 34 years 20 16.1 
35 - 44 years 61 49.2 
45 - 54 years 35 28.2 
55 - 64 years  7 5.6 
   Marital Status (N = 124) 
  Single 8 6.5 
Married/Common Law 100 80.6 
Separated 9 7.3 
Divorced 6 4.8 
   Annual Household Income (N = 120) 
  Under $25,000 11 8.9 
$25,000 - $49,999 27 21.8 
$50,000 - $74,999 24 19.4 
$75,000 and over 57 46.0 
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Education  (N = 124) 
  High School or Less 7 5.6 
Some College/University 22 17.7 
College/University or Post Graduate 94 75.8 
   Employment Status (N = 122) 
  Full Time 41 33.1 
Part Time 35 28.2 
Unemployed 42 33.9 
Retired 3 2.4 
   Current Country of Residence (N = 124) 
 Australia 21 16.9 
Canada 31 25.0 
India 3 2.4 
Indonesia 1 0.8 
Singapore 1 0.8 
United Kingdom 2 1.6 
United States of America 56 45.2 
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Children.  The age of the parents’ children was restricted to 21 years and under in the 
present study, as the National Standards Report – which was used in the present study to classify 
treatments in terms of their levels of empirical support – reviewed the efficacy of proposed 
treatments for children with ASD only under the age of 21 (NAC, 2009).  The majority of 
children (84.7%) were male, White (74.2%), and their mean age was 8.83 years.  All parents 
reported that their children had received diagnoses on the Autism Spectrum.  Their mean age at 
diagnosis was 47.87 months.  For more information regarding the demographic characteristics of 
participants’ children, please see Table 2.   
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Table 2 
Children Demographic Information 
Variable Number (%) 
   Race/Ethnicity (N = 123) 
  Black 3 2.4 
Chinese 4 3.2 
Filipino 2 1.6 
Latin American 3 2.4 
South Asian (East Indian, Pakistani, Sri Lankan, etc.) 3 2.4 
Southeast Asian (Cambodian, Indonesian, Laotian, Vietnamese,  
   etc.) 1 0.8 
White 92 74.2 
Other  13 10.5 
   Gender (N = 123) 
  Male 105 84.7 
Female 18 14.5 
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Materials 
 Since the present study took place online, the following questionnaires were provided in 
electronic format to participants.  Therefore, some elements of the formatting were adapted to 
accommodate this type of survey distribution.  The instructions, items, and rating systems 
remained unchanged, however. 
Demographic Questionnaire.  The questionnaire, designed for this study, consisted of 
14 items regarding parent and child demographics (e.g., gender, age, marital status, income, 
education, employment status, age at diagnosis, and race/ethnicity) and 1 item regarding 
treatments selected in the past, currently being used, or for which parents are currently waitlisted.  
For a copy of the demographic questionnaire, please see Appendix B.  The list of treatment 
options was compiled in accordance with the 37 intervention strategies reviewed by the National 
Autism Center (2009).  As shown in Table 3, the National Autism Center (2009) classified 11 
treatments as empirically “established”, 21 treatments as “emerging”, and 5 treatments as 
“unestablished” by reviewing the supporting research evidence and rating each treatment 
according to the Scientific Merit Rating Scale (SMRS: NAC, 2009).   
The National Autism Center evaluated five dimensions of the supporting evidence in 
order to assign a SMRS rating between 0 and 5 to each proposed treatment: (1) research design, 
(2) measurement of the dependent variable, (3) measurement of the independent variable or 
procedural fidelity, (4) participant ascertainment, and (5) generalization (National Standards 
Report, NAC, 2009).  SMRS ratings of 3, 4, or 5 indicate that the treatment has been studied 
with sufficient scientific rigor to say that the treatment is “established”.  SMRS ratings of 2 
indicate that the treatment is “emerging”, but that there is not yet enough empirical support 
behind the treatment to classify it as established. SMRS ratings of 1 or 0 indicate that the   
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Table 3 
National Autism Center Classifications of each Reviewed Intervention 
Established Emerging Unestablished 
Antecedent package Augmentative/alternative 
communication device 
Academic interventions 
Behavioural package Cognitive behavioural 
intervention package 
Auditory integration training 
Comprehensive behavioural 
treatment for young 




Joint attention intervention Exercise Gluten/casein-free diet 
Modeling Exposure package Sensory integrative package 
Naturalistic teaching strategies Imitation-based interaction  
Peer training package Initiation training  
Pivotal response treatment Language training 
(production)  
 
Schedules Massage/touch therapy  
Self management Multi-component package  
Story-based intervention 
package 
Music therapy  
 Peer-mediated instructional 
arrangement 
 
 Picture exchange 
communication system 
 
 Reductive package  
 Scripting  
 Sign instruction  
 Social communication 
intervention 
 
 Social skills package  
 Structured teaching  
 Technology-based treatment  
 Theory of mind training  
*Note. Classifications based on the Scientific Merit Rating Scale, developed by the National Autism Center.  
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treatment is “unestablished”, as it has not yet been studied with sufficient scientific rigor to 
substantiate any claims of efficacy in treating ASD.   
Revised Illness Perception Questionnaire- Autism (English).  For the purposes of the 
present study, the Revised Illness Perception Questionnaire-Autism (English) (IPQ-RA-E) was 
created by further modifying the Revised Illness Perception Questionnaire first adapted for ASD 
by Al Anbar, Dardennes, and Kaye (2010) in France.  Permission to use and modify this measure 
was obtained from Dardennes (see Appendix C).  For a copy of this revised measure, please see 
Appendix D.       
The Illness Perception Questionnaire (IPQ: Weinman, Petrie, Moss-Morris, & Horne, 
1996) was originally developed to quantify individuals’ illness representations in accordance 
with Leventhal’s self-regulation model of illness behaviour (Leventhal, Meyer, & Nerenz, 1980).  
Unfortunately, low internal consistency within two of the subscales was a limitation of the 
measure in its original form (Moss-Morriss, Weinman, Petrie, Horne, Cameron, & Buick, 2002).  
Moss-Morris and colleagues (2002) developed the revised Illness Perception Questionnaire 
(IPQ-R) to improve the internal consistency of the Control/Cure and Timeline subscales, and to 
include newer components of Leventhal’s self-regulation model of illness behaviour (Leventhal, 
Leventhal, & Contrada, 1999): cyclical timeline perceptions, illness coherence, and emotional 
representations of illness.  The IPQ-R is comprised of 73 items representing nine subscales 
designed specifically to measure the various aspects of illness representations proposed by 
Leventhal’s self-regulation model of illness behaviour (Leventhal, Meyer, & Nerentz, 1980; 
Leventhal, Leventhal, & Contrada, 1998): identity, causes, timeline (acute/chronic), timeline 
(cyclical), consequences, personal control, treatment control, emotional representations, and 
illness coherence.   
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The Identity subscale of the IPQ-R is designed to measure the number of symptoms an 
individual experiences and the number of symptoms an individual directly attributes to his/her 
illness.  This subscale is quantified by summing the number of symptoms experienced and the 
number of symptoms attributed to the illness (e.g., pain, sleep difficulties).  On the remaining 
subscales of the IPQ-R, individuals indicate on a 5-point Likert-type scale ranging from 
“strongly disagree” to “strongly agree” the extent to which they agree or disagree with a series of 
statements.  The Cause subscale of the IPQ-R is designed to measure an individual’s beliefs 
about the causes of his/her illness (e.g., stress or worry, hereditary).  The Timeline 
(Acute/Chronic) subscale of the IPQ-R is designed to measure how chronic the individual 
perceives the illness to be (e.g., “My illness will last a short time”), while the Timeline (Cyclical) 
subscale of the IPQ-R is designed to measure how cyclical or episodic an individual perceives 
the course of the illness to be (e.g., “My symptoms come and go in cycles”).   
The Consequences subscale of the IPQ-R is designed to measure the negative 
consequences an individual perceives are related to his/her illness (e.g., “My illness strongly 
affects the way others see me”).  The Personal Control subscale of the IPQ-R is designed to 
measure the amount of control an individual feels over his/her illness (e.g., “There is a lot which 
I can do to control my symptoms”).  The Treatment Control subscale of the IPQ-R is designed to 
measure the extent to which the individual feels that the illness can be controlled or cured 
through treatment (e.g., “My treatment will be effective in curing my illness”).  The Emotional 
Representations subscale of the IPQ-R is designed to measure an individual’s positive or 
negative emotional reactions to the illness (e.g., “I get depressed when I think about my illness”).  
Finally, the Illness Coherence subscale of the IPQ-R is designed to measure the extent to which 
the individual understands the illness (e.g., “The symptoms of my condition are puzzling to  
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me”).   
The psychometric properties of the IPQ-R have been studied extensively and are accepted 
as an improvement over those of the original IPQ (Figueiras & Alves, 2007; Moss-Morriss et al., 
2002; Wittkowski, Richards, Williams, & Main, 2008).  Adequate construct validity of the nine 
subscales has been demonstrated through exploratory and confirmatory factor analyses (Hagger 
& Orbell, 2003; Moss-Morriss et al., 2002).  The nine subscales of the IPQ-R have good internal 
reliability, with Cronbach’s alpha values ranging from .79 (Timeline Cyclical) to .89 (Timeline 
Acute/Chronic) (Moss-Morriss et al., 2002).  The three-week test-retest reliability for each 
subscale of the IPQ-R range from .46 to .88, with only the Personal Control subscale having a 
correlation below .50 (Moss-Morriss et al., 2002).  The test-retest reliability for each subscale of 
the IPQ-R has also been examined over six months, demonstrating correlations greater than .5 
for all subscales except the Timeline Cyclical subscale. 
The subscales of the IPQ-R have adequate discriminant validity with the Positive and 
Negative Affect Scale (Watson, Clark, & Tellegen, 1988), with correlations ranging from .01 to 
.36 (Moss-Morris et al., 2002).  Only the Emotional Representations subscale correlated 
somewhat highly (.54) with negative affect.  The subscales of the IPQ-R have also been shown to 
have adequate known group validity by producing significantly different scores from individuals 
with acute pain and individuals with chronic pain (Moss-Morriss et al., 2002).  In addition, 
illness representations have been shown to account for an additional 15% of variance in Sickness 
Impact Profile scores (Bergner, Bobbitt, Carter, & Gilson, 1981) above the 42% of variance 
accounted for by illness severity, demonstrating predictive validity (Moss-Morriss et al., 2002).  
Additional evidence of the predictive validity of the IPQ-R is that illness representations have 
been shown to significantly account for 27% of the variance in physical fatigue and 20% of the  
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variance in mental fatigue (Moss-Morriss et al., 2002).   
The IPQ-R was first revised for use with parents of children with ASD in 2005 by Al 
Anbar, Dardennes, and Kaye.  The IPQ-RA (Al Anbar, Dardennes, & Kaye, 2005) consists of 73 
French language items measuring the same nine subscales as the IPQ-R: Identity, Causes, 
Timeline (Acute/Chronic), Timeline (Cyclical), Consequences, Personal Control, Treatment 
Control, Emotional Representations, and Illness Coherence.  Al Anbar, Dardennes, and Kaye 
(2005) did, however, modify the phrasing of IPQ-R items to assess parents’ representations of 
their children’s ASD instead of individuals’ representations of their own illnesses and by 
changing the word “illness” in the IPQ-R to the word “disorder” in the IPQ-RA.  This was 
thought to more accurately reflect the nature of ASD.  The symptom checklist in the identity 
scale was also modified to include the symptoms of ASD outlined in the Diagnostic and 
Statistical Manual of Mental Disorders-III- Revised (APA, 1987).   
With the permission of the authors of the IPQ-R and the IPQ-RA, the IPQ-RA-E was 
designed by modifying the IPQ-RA in three ways: (1) presenting items in English using the 
phrasing from the original IPQ-R (Moss-Morriss et al., 2002), (2) updating the Identity subscale 
to include the symptoms of ASD outlined in the Diagnostic and Statistical Manual of Mental 
Disorders-IV-TR (APA, 2000), and (3) modifying the Cause subscale to include statements 
pertaining to causes more specifically associated with ASD (e.g., vaccine injury).  These ASD-
specific causes were developed using those mentioned in Furnham and Buck’s (2003) Lay 
Beliefs about Autism Questionnaire (as has been done by Dardennes, Al Anbar, Prado-Netto, 
Kaye, Contejean, and Al Anbar [2011]) as well as additional causes popularly cited by parents of 
children with ASD.  This new IPQ-RA-E consists of 78 items. 
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Acceptance and Action Questionnaire-II (Autism).  The Acceptance and Action  
Questionnaire-II (AAQ-II: Bond et al., in press) was used in the present study to assess parents’ 
acceptance of their children’s ASD.  Permission to use and modify this measure was obtained 
from Bond (see Appendices E and F, respectively).  For a copy of this revised measure, please 
see Appendix G.   
Originally, the AAQ-II was designed to assess individuals’ general tendencies toward 
acceptance (i.e., “the willingness to experience unwanted private events, in order to pursue one’s 
values and goals”, [Hayes, Wilson, Gifford, Follette, & Strosahl, 1996]). It was designed to 
address the weaknesses of comprehension and reliability inherent in the original AAQ developed 
by Hayes et al. (2004).  The AAQ-II is comprised of 10 items which are rated on a 7-item Likert 
scale ranging from “never true” to “always true” (e.g., “It’s OK if I remember something 
unpleasant”).   
The psychometric properties of the AAQ-II have been studied recently in 2816 
participants across six samples (Hayes et al., 2011) and it was concluded that the AAQ-II 
measures the same construct as the original AAQ (r = .97), but has the advantage of improved 
psychometric consistency.  The AAQ-II has demonstrated good internal reliability, with 
Cronbach’s alpha coeffiecients of the six tested samples ranging from .78 to .88 (Hayes et al., 
2011).  In addition, the AAQ-II has good three-month test-retest reliability, with a correlation of 
.81, and twelve-month test-retest reliability, with a correlation of .79 (Hayes et al., 2011).   
In terms of predictive validity, higher scores on the AAQ-II (i.e., more experiential 
avoidance) have been found to be associated, as expected, with higher scores on the Beck 
Depression Inventory-II (Beck, Steer, & Brown, 1996), higher scores on the Depression Anxiety 
Stress Scales (Lovibond & Lovibond, 1995), and greater psychological distress one year later 
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(Bond & Hayes, 2002) as measured by the General Health Questionnaire (Goldberg, 1978).  The 
AAQ-II has also demonstrated adequate convergent validity with the White Bear Suppression 
Inventory (Wegner & Zanakos, 1994), with a correlation of .63 (Bond et al., 2002).  In addition, 
the AAQ-II has demonstrated excellent divergent validity with the Marlowe-Crowne Social 
Desirability Scale (Crowne & Marlowe, 1960), with a nonsignificant correlation of -.09 between 
these two measures (Bond et al., 2002). 
For the purposes of the present study, the AAQ-II was modified to create the Acceptance 
and Action Questionnaire-II (Autism) (AAQ-II-A) by rephrasing the 10 items to refer 
specifically to individuals’ acceptance in relation to their children’s ASD (e.g., “It’s OK if I 
remember something unpleasant about my child with ASD”).  This type of modification has also 
recently been performed by MacDonald, Hastings, and Fitzsimons (2010) in order to measure 
parents’ acceptance of their children’s intellectual disabilities.   
Marlowe-Crowne Social Desirability Scale- Short Form.  Although the AAQ-II has 
been found not to be significantly associated with the Marlowe-Crowne Social Desirability Scale 
(Bond et al., 2011), this relation has not yet been studied using the AAQ-II-A or the IPQ-RA-E.  
As such, the Marlowe-Crowne Social Desirability Scale- Short Form (MCSDS-SF: Strahan & 
Gerbasi, 1972) was included in the present study in order to control for possible confounds 
within these measures.  Permission to use this measure was not necessary to obtain, since this 
measure is in the public domain.  For a copy of this measure, please see Appendix H.   
The original MCSDS (Crowne & Marlowe, 1960) was developed in order to detect and 
quantify individuals’ (intentional or unintentional) attempts to present themselves in a socially 
desirable or undesirable light.  It was comprised of 33 items consisting of statements which 
respondents are asked to judge as “true” or “false” based on their experiences (e.g., “I never  
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hesitate to go out of my way to help someone in trouble”).   
In terms of psychometric properties, the original MCSDS has demonstrated good internal 
reliability, with a calculated reliability coefficient of .88 using the Kuder-Richardson formula 
(Crowne & Marlowe, 1960).  Additionally, the MCSDS has also been demonstrated to have 
excellent one-month test-retest reliability, with a correlation of .89 between tests (Crowne & 
Marlowe, 1960).  As expected, the MCSDS is also significantly correlated (r = .35) with the 
Edwards Social Desirability Scale, demonstrating convergent validity with this measure (Crowne 
& Marlowe, 1960).  
As the present study involved several measures, a short form of the original MCSDS, 
developed by Strahan and Gerbasi (1972), was used in order to minimize potential fatigue effects 
and strain on participants.  The MCSDS short form (MCSDS-SF: Strahan & Gerbasi, 1972) is 
comprised of ten items from the original MCSDS (Crowne & Marlowe, 1960; e.g., “I’m always 
willing to admit when I make a mistake”, “I like to gossip at times”).  The MCSDS-SF has 
demonstrated adequate internal reliability, with calculated reliability coefficients ranging from 
.59 to .70 in four different populations (Strahan & Gerbasi, 1972).  In addition, the MCSDS-SF 
has demonstrated excellent convergent validity with the original MCSDS, with a correlation 
above .80 between the measures (Strahan & Gerbasi, 1972).   
Open-Ended, Exploratory Survey Questions.  Four open-ended, exploratory survey 
items were developed specifically for the present study in addition to the previously mentioned 
quantitative measures.  Please see Appendix I for a copy of these open-ended items.  These items 
provided parents with the opportunity to respond freely to questions surrounding their goals for 
treatment programs, the most important factors in their treatment selection, how their feelings 
about ASD have changed since initial diagnosis, and their conceptualizations of ASD.   
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In-Depth Interview Questions.  In an effort to develop a more in-depth understanding of 
how parents think of ASD, acceptance, and treatment selection, a semi-structured follow-up 
interview protocol was also developed.  This interview consisted of a series of six questions 
designed to provide additional insight into parents’ responses to the online questionnaire items.  
Parents were asked about what ASD means to them, what has influenced the way they think 
about ASD, what it means to accept one’s child’s ASD, what has influenced their acceptance, 
what challenges they have experienced in selecting treatments, and what advice they would like 
to offer other parents of children with ASD.   Please see Appendix J for a copy of these in-depth 
interview questions. 
Procedure  
Participants were asked to follow the link provided in the recruitment advertisements and 
flyers to an Internet website that had been set up for the current study.  Upon navigating to the 
Internet site, participants were presented with a consent form to participate in the online study.  
This form contained information regarding the potential benefits and risks of participating in the 
present study.  Please see Appendix K for a copy of this consent form.  For the purposes of the 
study, clicking the “Yes” in response to the item “I consent to participate” was taken to indicate 
that participants had given their informed consent to participate.    
Next, participants were presented with the demographic questionnaire, as Reips (2011) 
demonstrated that early presentation of demographic items is associated with lower dropout rates 
and fewer missing data in online research.  The IPQ-RA (English), the AAQ-II (A), and the 
MCSDS were then presented in counterbalanced order (determined by the child’s birth month) to 
control for possible fatigue effects.  That is, each participant completed each of these three 
measures, but their order of presentation varied between participants.  At this time, participants 
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had the option to respond to several open-ended questions designed to gather exploratory 
information regarding factors influencing their cognitive representations of ASD and their 
treatment selection for their children.  These questionnaires (including both the survey items and 
the open-ended items) took participants an average of 51.13 minutes to complete.  Although this 
completion time was longer than the originally estimated completion time based on pilot testing 
with a Parent Advisor (20 minutes), it should be noted that the online administration format of 
the survey allowed parents to leave their computers or take short breaks between items.  It is 
believed that this flexible administration is largely responsible for the longer completion time in 
the actual study. 
Once all measures were completed, participants were asked to enter their email addresses 
if they wanted to participate in a draw for one of ten $20 electronic gift cards as a token of thanks 
for participating.  This draw took place upon completion of data collection for the present study.  
Several smaller incentives were offered in the present study rather than fewer larger incentives in 
order to afford participants greater likelihood of being selected and because the monetary value 
of incentives has been found to be unrelated to response quality in online research (Goritz, 
2004).  By presenting participants with an electronic gift card as an incentive, participants’ home 
addresses did not need to be obtained, maximizing the participant confidentiality and privacy.  
Finally, participants were asked to indicate whether they agreed to be contacted by the primary 
researcher for a follow-up interview over the telephone.  All participants were then presented 
with a printable letter of information describing the background, purpose, and hypotheses of the 
current study.  This post-study letter of information also contained links to the National 
Standards Report (NAC, 2009) and the Evidence-Based Practices for Children and Adolescents 
with Autism Spectrum Disorders report (Children’s Mental Health Ontario, 2003), which contain 
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thorough reviews of the empirical evidence for several proposed treatments for ASD and 
recommendations for parents when selecting treatments for their children.  For a copy of this 
post-study letter of information, please see Appendix L. 
From the participants who agreed to be contacted for the follow-up telephone interview, 
ten were selected by convenience to complete these more in-depth interviews.  Although only 
participants living in the United States and Canada were selected, an effort was made to include 
participants from diverse areas of these two countries.  These participants were contacted by 
telephone, explained what the interview would involve, and assured that confidentiality would be 
strictly respected.  Interviews were then scheduled with participants who had given their 
informed consent to the primary investigator orally.  These interviews took place over the 
telephone and required approximately twenty minutes to complete.  Interviews were digitally 
recorded and later transcribed by trained undergraduate research assistants.  All data were 
collected between June 21, 2012 and August 9, 2012. 
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Results 
Preliminary Analyses  
Before beginning the tests of hypotheses in the present study, the data set was assessed to 
identify missing data and outliers.  A total of 12 cases were excluded listwise from subsequent 
analyses due to a survey host error which resulted in failing to present these participants with the 
demographic questionnaire.  Only the remaining 134 cases were included for further 
examination.  Since missing data comprised only 1.44% of this data set, cases containing missing 
data were excluded listwise from analyses, as recommended by Schafer (1999).  Within the data 
set, a total of 5 outliers (i.e., values greater than 2.5 standard deviations from the mean) were 
identified and were excluded from subsequent analyses because it appeared that these 
participants had meaninglessly endorsed items (e.g., selected “1” for every item in a 
questionnaire).  An additional 3 participants were excluded from analyses because their children 
were born prior to 1991.  This left a total of 124 cases in the present data set. 
In addition, the extent to which the assumptions of logistic regression had been met in the 
data set was determined for the first set of hypotheses.  These assumptions include: (a) statistical 
independence of outcomes, (b) linearity of the logit, (c) multicollinearity, and (d) adequate 
sample size (i.e., 50 participants per predictor variable) (Field, 2009; Wright, 2000).  Since each 
participant completed the online questionnaire only once, the assumption of independence of 
outcomes was said to have been met.  Examination of interactions between predictors and their 
log transformations did not reveal any significant violations of the assumption of linearity of the 
logit.  Tolerance values were greater than 0.1 and Variance Inflation Factor (i.e., VIF) values 
were less than 10 for each predictor variable, indicating no issues with multicollinearity in the 
present data set.  Finally, with a total of 124 participants and no more than two predictor 
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variables per logistic regression analysis, the assumption of adequate sample size was met in the 
present data set.   
Since the second set of hypotheses in the present study was tested using bivariate 
correlations (Pearson’s r), the extent to which the assumptions of this method of data analysis 
had been met in the present data set was determined as well.  These assumptions include: (a) 
interval-level data and (b) a normally-distributed sampling distribution (Field, 2009).  The AAQ-
II-A and the section of the Demographic Questionnaire concerning treatments selected by 
parents both yield interval-level data, so this assumption was said to have been met in the present 
data set.  Additionally, the extent to which the assumption of normally-distributed variables was 
met in the present data set was determined by examining skewness values, kurtosis values, and 
histograms for the variables of interest.   
For all variables, the skewness values were between -2 and 2, indicating appropriate 
symmetry of the distributions for the variables (Cohen, Cohen, West, & Aiken, 2003).  For all 
variables, the kurtosis values were between 3 and -3, indicating roughly mesokurtic distributions 
(i.e., distributions with appropriately high peaks and sharp tails) (Cohen, Cohen, West, & Aiken, 
2003).  Finally, visual inspection of the histograms for each variable revealed distributions 
approximating normality.  Thus, the assumption of normally-distributed variables was said to 
have been satisfied in the present data set. 
Descriptive statistics.  Participants in the present study completed measures of the 
treatments they had selected for their children with ASD, their acceptance of their children’s 
diagnosis of ASD, and several aspects of their cognitive representation of ASD.  The descriptive 
statistics for these study variables are outlined below. 
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Treatments selected.  Parents in the present study reported selecting several treatments 
for their children with ASD.  The five most commonly selected treatments were antecedent 
package, behavioural package, academic interventions, schedules, and gluten/casein-free diet, 
respectively.  Please see Table 4 for a detailed view of parents’ selections.  The treatments 
selected by parents were also categorized into levels of empirical support (i.e., established, 
emerging, or unestablished) according to the National Standards Report (NAC, 2009).  Parents 
reported selecting an average of 16 treatments for their children with ASD, the majority of which 
were classified as empirically “emerging”.  Please see Table 5 for a detailed view of the levels of 
empirical support of treatments selected by parents of children with ASD. 
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Table 4 
Treatments/Interventions Selected by Parents 
Intervention 
Total   Past Present Waitlist 
#           % #           % #             % #             % 
Antecedent package 98 79 32 25.8 51 41.1 15 12.1 
Behavioural package 89 71.8 24 19.4 54 46.9 10 8.1 
Academic interventions 87 70.2 21 16.9 54 43.5 12 9.7 
Schedules 81 65.3 24 19.4 57 46 1 0.8 
Gluten/casein-free diet 76 61.3 33 26.6 31 25 12 9.7 
Social skills package 76 61.3 22 17.7 44 35.5 9 7.3 
Comprehensive 
   behavioural treatment 
73 58.9 27 21.8 33 26.6 11 8.9    for young children 
Language training 
72 58.1 24 19.4 39 31.5 9 7.3    (production) 
Auditory integration 
71 57.3 28 22.6 8 6.5 17 13.7    training 
Story-based intervention 
70 56.5 29 23.4 35 28.2 6 4.8    package 
Sensory integrative 
68 54.8 26 21 28 22.6 13 10.5    package 
Exercise 67 54 12 9.7 50 40.3 4 3.2 
Cognitive behavioural 
61 49.2 11 8.9 37 29.8 13 10.5    intervention package 
Modeling 60 48.4 24 19.4 27 21.8 10 8.1 
Naturalistic teaching 
60 48.4 16 12.9 36 29 9 7.3    strategies 
Augmentative/alternative 
57 46 16 12.9 30 24.2 10 8.1    communication device 
Developmental 
57 46 19 15.3 23 18.5 14 11.3 
   relationship-based 
   treatment 
Initiation training 57 46 17 13.7 32 25.8 8 6.5 
Language training 
57 46 11 8.9 35 28.2 11 8.9 
   (production and 
   understanding) 
Self management 57 46 24 19.4 23 18.5 10 8.1 
Social communication 
54 43.5 15 12.1 22 17.7 17 13.7    intervention 
Joint attention 53 42.7 10 8.1 31 25 12 9.7 
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   intervention 
Scripting 53 42.7 22 17.7 21 16.9 10 8.1 
Massage/touch therapy 52 41.9 27 21.8 19 15.3 6 4.8 
Picture exchange 
52 41.9 25 20.2 19 15.3 6 4.8    communication system 
Sign instruction 44 35.5 28 22.6 11 8.9 5 4 
Music therapy 41 33.1 22 17.7 9 7.3 9 7.3 
Peer-mediated 38 30.6 10 8.1 20 16.1 8 6.5 
   instructional 
           arrangement 
        Peer training package 38 30.6 12 9.7 17 13.7 9 7.3 
Structured teaching 36 29 10 8.1 15 12.1 11 8.9 
Exposure package 32 25.8 6 4.8 14 11.3 12 9.7 
Imitation-based 
32 25.8 13 10.5 14 11.3 5 4    interaction 
Pivotal response 
30 24.2 9 7.3 9 7.3 12 9.7    treatment 
Technology-based 
30 24.2 4 3.2 15 12.1 11 8.9    treatment 
Facilitated 
29 23.4 5 4 13 10.5 10 8.1    communication 
Multi-component 
27 21.8 7 5.6 9 7.3 11 8.9    package 
Theory of mind training 27 21.8 6 4.8 8 6.5 13 10.5 
Other 21 19.4 
      Reductive package 16 12.9 3 2.4 3 2.4 11 8.9 
 
*Note. Some parents did not indicate when they had used each treatment with their children. 
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Table 5 
Number of Treatments Selected with each Level of Empirical Support 
 
Empirical Classification N M SD Min. Max. 
 
Established 121 5.76 3.29 0 11 
 


























*Note. Empirical classifications are in accordance with the National Standards Report (NAC, 2009). 
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Acceptance.  Participants completed the AAQ-II-A as a measure of their acceptance of 
their children’s diagnosis of ASD.  Recall that higher scores on the AAQ-II-A represent lower 
levels of acceptance.  Table 6 displays the descriptive statistics for the AAQ-II-A. 
Cognitive representations of ASD.  Participants completed the IPQ-RA-E as a measure 
of their cognitive representations of their children’s ASD.  For the purposes of the present study, 
the Consequences, Cyclical Course, Personal Control, and Emotional Representations subscales 
were of interest.  Table 6 also displays the descriptive statistics for these subscales of the IPQ-
RA-E. 
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Table 6 
Descriptive Statistics for Study Variables 
 
Measure/Subscale N M SD Min. Max. 
 
IPQ-RA-E 
      
Consequences Subscale 124 23.96 4.36 13 30 
 
Cyclical Course Subscale 122 11.76 3.19 5 20 
 
Personal Control Subscale 124 23.30 4.98 9 30 
 
Emotional Representations Subscale 122 16.31 7.11 1 30 












*Note. Higher scores on the AAQ-II-A represent lower levels of acceptance. 
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Tests of Hypotheses 
Since the outcome variables for Hypothesis I (a through e) were dichotomous (i.e., “use” 
or “non-use” of behavioural, medication-based, or metabolic treatments), binomial logistic 
regressions were used in these analyses (Cohen, Cohen, West, & Aiken, 2003).  Although 
discriminant analysis may also be used in examining relations between several predictors and a 
categorical dependent variable, this type of analysis has more restrictive assumptions (e.g., 
normally-distributed predictors; Wright, 2000); thus, logistic regression was used in the present 
study.  Predictor variables were entered hierarchically in order of their predictive power as 
demonstrated by Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010).  The 
bonferonni adjustment for multiple tests was not used in these analyses in accordance with the 
recommendations of Perneger (1998).  Since there were only three statistical tests being 
performed and hypotheses were informed by previous research, applying the bonferonni 
adjustment would likely have over-inflated the type-II error rate (i.e., the chances of failing to 
detect a truly significant result) in the present study.  Instead, Perneger’s (1998) recommendation 
of simply describing each test of significance performed was followed. 
Prior to conducting any tests of hypotheses, bivariate correlations between parents’ scores 
on the MCSDS-SF and the other variables of interest were examined.  Since parents’ scores on 
the MCSDS-SF were not significantly correlated with parents’ scores on any of the other 
variables of interest, it was unnecessary to include social desirability as a control variable in 
subsequent analyses.   
Hypothesis I: Cognitive representations of ASD.  Table 7 presents a summary of the 
results of the logistic regression analyses testing this first set of hypotheses. 
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Table 7 
Logistic Regression Analyses Predicting Types of Treatments Selected 
 
              95% CI for Exp(B) 
  
B SE Wald's χ² R² eᵝ  Lower Upper 














































Belief in Cyclical  
Timeline -0.08 0.13 0.40 0.01 
 
 





























































* p < .05, **p = .001. 
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1a: Belief in consequences.  Higher beliefs in the severity of ASD and its impact on 
various aspects of one’s child’s functioning did not significantly predict group membership for 
selecting behavioural treatments, Block χ² (1, N = 124) = 1.08, ns.  Therefore, this hypothesis 
was not supported in the present study. 
1b: Belief in timeline.  Higher beliefs in a cyclical course of ASD symptomatology did 
not significantly predict group membership for selecting medication-based treatments, Block χ² 
(1, N = 124) = 0.40, ns. Therefore, this hypothesis was not supported in the present study. 
1c: Belief in control.  Higher beliefs in personal control over one’s child’s ASD 
significantly predicted group membership for selecting medication-based treatments, Block χ² (1, 
N = 124) = 4.12, p < .05, correctly predicting 93.7% of participants’ group membership.  This 
model accounted for approximately 21% of the variation in parents’ selection of medication-
based treatments for their children with ASD (Nagelkerke R² = 0.21).  Belief in personal control 
over one’s child’s ASD was the only significant predictor of selecting medication-based 
treatments (B = 0.43, Wald = 4.12, p < .05).  Parents with greater beliefs in their personal control 
over ASD were more likely to select medication-based treatments for their children (odds ratio = 
1.54; 95% CI = 1.01 to 2.33).  Therefore, this hypothesis was supported in the present study. 
Higher beliefs in personal control over one’s child’s ASD did not significantly predict 
group membership for selecting metabolic treatments, Block χ² (1, N = 124) = 1.90, ns. 
Therefore, this hypothesis was not supported in the present study. 
1d: Belief in external causes.  Higher beliefs in external causes (i.e., pollution, diet, germ 
or virus, poor medical care in the past, altered immunity, vaccine injury, food allergies, toxic 
metals in the bloodstream, videos the child watched) of one’s child’s ASD significantly predicted 
group membership for selecting metabolic treatments, Block χ² (1, N = 124) = 11.51, p = .001, 
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correctly predicting 71.3% of participants’ group membership.  This model accounted for 
approximately 18.3% of the variation in parents’ selection of metabolic treatments for their 
children with ASD (Nagelkerke R² = 0.183).  Belief in external causes of one’s child’s ASD was 
a significant predictor of selecting metabolic treatments (B = 0.33, Wald = 11.51, p = .001).  
Parents with greater beliefs in external causes of ASD were more likely to select metabolic 
treatments for their children (odds ratio = 1.40; 95% CI = 1.15 to 1.69).  Therefore, this 
hypothesis was supported in the present study. 
1e: Negative emotional representations.  More negative emotional reactions to one’s 
child’s diagnosis of ASD did not significantly predict group membership for selecting 
behavioural treatments, Block χ² (1, N = 122) = 0.37, ns. Therefore, this hypothesis was not 
supported in the present study. 
Hypothesis II: Acceptance of children’s ASD.  Table 8 presents a summary of the 
results of the bivariate correlation analyses testing this second set of hypotheses. 
2a: High acceptance of ASD.  Parents’ scores on the AAQ-II-A (which measures 
parents’ experiential avoidance of their thoughts and emotions relating to their child’s ASD) 
were significantly positively correlated with the number of empirically supported treatments they 
selected for their children, r = .179, p < .05.  Therefore, data from the study supported an 
alternative hypothesis.  In other words, parents with higher levels of acceptance of their 
children’s ASD selected significantly fewer empirically supported treatments for their children 
than did parents with lower levels of acceptance of their children’s ASD.  Parents’ acceptance of 
their children’s ASD accounted for 3.20% of the variance in the number of empirically supported 
treatments they selected for their children, R² = 0.032.  According to Cohen (1988), this  
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Table 8 
Bivariate Correlation Analyses Predicting Empirical Classifications of Treatments Selected 
Variables   1 2 3 
1. (Lack of) Acceptance  -  
   
2. Established Treatments Selected 0.18*   -  
  






 -  
 
*p < .05. **p < .001. 
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represented a small effect size. 
2b: Low acceptance of ASD.  Parents’ scores on the AAQ-II-A (which measures parents’ 
experiential avoidance of their thoughts and emotions relating to their child’s ASD) were 
significantly positively correlated with the number of empirically unsupported treatments they 
selected for their children, r = .211, p < .05.  Therefore, this hypothesis was supported in the 
present study.  In other words, parents with lower levels of acceptance of their children’s ASD 
selected significantly more empirically unsupported treatments for their children than parents 
with higher levels of acceptance of their children’s ASD.  Parents’ acceptance of their children’s 
ASD accounts for 4.45% of the variance in the number of empirically unsupported treatments 
they selected for their children, R² = 0.044.  According to Cohen (1988), this represented a small 
effect size.   
Exploratory Quantitative Analyses 
Since many of the hypotheses in the present study were not supported by data collected 
from the present sample, the data were explored in greater detail in order to more closely 
examine possible reasons behind this.  The following results should, therefore, be reviewed with 
caution, as they were not guided by previous research or subjected to the same level of statistical 
scrutiny as the main study findings.  As noted by Hand (1998), this type of “data fishing” can be 
dangerous because, with enough examination, almost any data set will yield patterns of some 
kind.  What is not clear without significance testing, though, is whether or not these patterns are 
merely the result of random variance.   
An unexpected correlation was found between the number of evidence-based treatments 
and the number of non evidence-based treatments selected by parents.  More specifically, parents 
who selected more evidence-based treatments for their children with ASD also reported selecting 
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more non evidence-based treatments for their children with ASD, r = .63, p < .001.  According to 
Cohen (1988), this represented a large effect size. 
Additionally, parents (N = 20) who reported selecting the most (i.e., 30 or more) 
treatments for their children were compared to parents (N = 11) who reported selecting the 
fewest (i.e., 5 or fewer) treatments for their children in an attempt to identify additional variables 
which may affect the number of treatments selected by parents.  As expected based on other 
findings from the present study, parents who reported selecting the most treatments for their 
children had AAQ-II-A scores reflecting lower levels of acceptance (M = 51.73) than parents 
who reported selecting the fewest treatments for their children (M = 34.15).   
Although there were was little difference between the age, education level, or household 
income of the parents in either group, children of parents who reported selecting the fewest 
treatments were found to be older (M = 13 years) than children of parents who reported selecting 
the most treatments (M = 9 years).  Children of parents who reported selecting the fewest 
treatments were also diagnosed at a later age (M = 51.33 months) than children of parents who 
reported selecting the most treatments (M = 36.29 months).  Another interesting difference 
between parents who reported selecting many treatments and parents who reported selecting few 
treatments was their countries of residence.  Parents who reported selecting the fewest treatments 
lived in Australia (36.4%), the United States (36.4%), and Canada (27.3%), while parents who 
reported selecting the most treatments lived in the United States (65%), Canada (20%), Australia 
(10%), and India (5%).   
It was also of interest to compare parents who selected only empirically supported 
treatments for their children (N = 8) to parents who selected only empirically unsupported 
treatments for their children (N = 5).  Several differences were found between these groups.  
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Perhaps most strikingly, parents who selected only empirically supported treatments for their 
children had AAQ-II-A scores reflecting higher levels of acceptance (M = 47.12) than parents 
who selected only empirically unsupported treatments for their children (M = 60.80).  
Additionally, more of the parents who selected only empirically supported treatments for their 
children were highly educated (100% reported completing college or postgraduate study) than 
parents who selected only empirically unsupported treatments for their children (40% reported 
completing some college, 40% reported completing college or postgraduate study, 20% reported 
completing high school or less).  Parents who selected only empirically supported treatments for 
their children identified as White (62.5%), Filipino (25%), and Southeast Asian (12.5%), while 
parents who selected only empirically unsupported treatments for their children identified as 
White (100%).   
In terms of child-related variables, it was found that children of parents who selected only 
empirically supported treatments were younger (M = 9 years of age) than children of parents who 
selected only empirically unsupported treatments (M = 14 years of age).  Similarly, children of 
parents who selected only empirically supported treatments were diagnosed at younger ages (M 
= 37.25 months of age) than children of parents who selected only empirically unsupported 
treatments for their children (M = 64.75 months of age).  Finally, children of parents who 
selected only empirically supported treatments were diagnosed more recently (M = 37.25 months 
ago) than children of parents who selected only empirically unsupported treatments (M = 82.75 
months ago). 
Parents (N = 11) with the highest levels of acceptance of their children’s ASD (i.e., 
parents with AAQ-II-A scores of 40 or lower) were also compared with parents (N = 11) with the 
lowest levels of acceptance of their children’s ASD (i.e., parents with AAQ-II-A scores of 65 or 
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higher).  It was found that parents with the lowest levels of acceptance had stronger beliefs in 
their personal control over their children’s ASD (M = 26) than parents with the highest levels of 
acceptance (M = 22.18).  Interestingly, parents with the highest levels of acceptance of their 
children’s ASD reported having more negative emotional reactions to the diagnosis of ASD (M = 
18.36) than did parents with the lowest levels of acceptance (M = 12.91).  It also appeared that 
more of the parents with the highest levels of acceptance of their children’s ASD were highly 
educated (100% reported completing college or postgraduate study) than parents with the lowest 
levels of acceptance (72.7% reported completing college or postgraduate study, 27.3% reported 
having some college education).   
Parents with the lowest levels of acceptance of their children’s ASD reported identifying 
as White (81.8%), Black (9.1%), and South Asian (9.1%), while parents with the highest levels 
of acceptance reported identifying as White (63.6%), Other, (18.2%), Filipino (9.1%), and South 
East Asian (9.1%).  Additionally, parents with the lowest levels of acceptance of their children’s 
ASD lived in the United States (54.5%), Canada (36.4%), and Australia (9.1%), while parents 
with the highest levels of acceptance of their children’s ASD lived in the United States (36.4%), 
Canada (27.2%), Australia (18.2%), and India (18.2%).  There were no differences between the 
two groups on child-related factors.   
Next, parents (N = 11) with the most negative emotional reactions to their children’s ASD 
diagnoses (i.e., parents with scores of 25 or higher on the IPQ-RA-E emotional representations 
subscale) were compared to parents (N = 24) with the least negative emotional reactions to their 
children’s diagnoses (i.e., parents with scores of 10 or lower on the IPQ-RA-E emotional 
representations subscale) in order to explore possible underlying factors associated with this 
construct.  It was found that children of the parents with the most negative emotional reactions to 
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their children’s diagnoses were diagnosed more recently (M = 43.25 months ago) than were the 
children of parents with the least negative emotional reactions to their children’s diagnoses (M = 
64 months ago).  Interestingly, parents with the most negative emotional reactions to their 
children’s diagnoses endorsed more external causes (M = 4.55) for their children’s ASD than did 
parents with the least negative emotional reactions to their children’s diagnoses (M = 1.17).   
Thematic Analysis of Open-Ended Survey and Interview Questions 
Data gathered from the four exploratory items and the in-depth interviews were analyzed 
using the method of conducting thematic analysis recommended by Braun and Clarke (2006).  In 
accordance with this method, data were first read through and initial themes were noted.  These 
initial themes, developed by the primary investigator, were then read through by the primary 
investigator, Parent Advisor, and research advisor for the study and were collated to form larger 
themes.  One exception to this is that parents’ responses to the four exploratory items were 
analyzed by only the primary researcher and the Parent Advisor.  Throughout this process, the 
specific aspects of each theme were refined and clear definitions and labels were generated for 
each theme.  Finally, particularly vivid quotations which accurately reflected each theme and the 
overall story of the data set were selected for inclusion in the final report.  This procedure helped 
to ensure that results accurately reflected the experiences of parents of children with ASD.    
Themes were reported in order of the number of parents whose comments comprised each theme 
(i.e., from most parents to fewest parents). 
Ultimate goal for child’s treatment/intervention.  Parents (N = 116) responded to the 
first open-ended survey item, which asked what their ultimate goal was for their children’s 
treatment or intervention programs.  The following themes were developed according to the 
procedures described above. 
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To live a happy and fulfilling life.  Parents (N = 27) reported that their ultimate goal for 
their children’s treatment was for them to be able to achieve the highest quality of life.  For 
example, parents’ responses included: “To teach my son skills…so he can have a happy and 
productive life”, “For him to live well”, and “I want to improve the quality of his life to the 
fullest extent possible”.   
To be able to live independently.  Parents (N = 25) reported that their ultimate goal for 
their children’s treatment was for them to eventually have the ability to live independently.  For 
example, parents’ responses included: “For him to be independent and successful at what he 
chooses to do in life”, “That he be able to function independently”, and “Functional, 
independent, tax-paying adult”. 
To reach his/her full potential.  Parents (N = 24) often reported that their main goal for 
their children’s treatment programs is to help their children achieve the most they are capable of.  
For example, parents’ responses included: “To help him function better, not to cure” and “For 
her to be the best her she can be”. 
To fully recover from ASD.  Parents (N = 17) reported that their main goal for their 
children’s treatment program is for their children to no longer have ASD.  For example, parents’ 
responses included: “Complete indistinguishability from same-age peers”, “Complete recovery”, 
and “Back to normal”.   
To master specific skills.  Parents (N = 16) reported that their ultimate goal for their 
children’s treatment program was for their children to gain skills in specific areas.  For example, 
parents’ responses included: “Verbal appropriate communication, social interactions, and 
significant reduction in sensory processing issues”, “For him to achieve developmental, speech, 
and physical goals on his peers’ level”, and “I would love her to be able to go to the toilet  
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without prompting 100% of the time and say ‘I love you mum’”.   
To form relationships with others.  Parents (N = 11) reported that their main goal for 
their children’s treatment program is for their children to form meaningful relationships with 
others.  For example, parents’ responses included: “To help him make friends and fit in” and 
“Ability to form relationships”.   
Most important factor when selecting treatments for a child with ASD.  Parents (N = 
117) responded to the second open-ended survey item, which asked about the most important  
factor to them when they selected treatments for their children with ASD.  The following themes 
were identified: 
How well the treatment works.  Parents (N = 24) reported that their main concern when 
selecting treatments for their children is how well the treatment works with their children.  For 
example, parents’ responses included: “That I am able to see results” and “Do they work well 
with my child?”.   
That the treatment is a good fit for the child.  Parents (N = 22) reported that their main 
concern when they were selecting treatments for their children was that the treatment addresses 
their children’s specific needs and characteristics.  For example, parents’ responses included: 
“Geared towards his needs”, “How suitable it is for my son”, and “How they will specifically 
target a problem my child has on an individual level”. 
That the treatment is evidence-based.  Parents (N = 21) reported that their main concern 
when selecting treatments for their children is that the treatment has empirical support.  For 
example, parents’ responses included: “The science behind it” and “Research-based with proven 
success”.   
That the treatment is not harmful.  Parents (N = 10) reported that their main concern  
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when selecting treatments for their children is that the treatment will not harm their children.  For 
example, parents’ responses included: “Firstly, that it will not harm my child” and “That they 
cause little or no harm to my son’s health or wellbeing”. 
Cost and availability of the treatment.  Parents (N = 10) reported that practical issues are 
their main concern when selecting treatments for their children with ASD.  For example, parents’ 
responses included: “What’s available” and “Money/insurance”.   
Advice from professionals and other parents of children with ASD.  Parents (N = 9) 
reported that advice from professionals working in the field of ASD and other parents of children 
with ASD are their main concern when selecting treatments for their children with ASD.  For 
example, parents’ responses included: “Recommendations by psychologist and pediatrician” and  
“Listening to other parents’ experiences”.   
Changes in feelings about child’s ASD from diagnosis to present.  Parents (N = 116) 
responded to the third open-ended survey item, which asked how their feelings about their 
children’s diagnoses have changed over time.  The following themes were identified: 
More accepting of the diagnosis now.  Parents (N = 32) reported that their acceptance of 
their children’s ASD had increased since their children were diagnosed.  For example, parents’ 
responses included: “I have become more accepting of it but without losing resolve to continue 
intensive therapies”, “The immediate grief has passed and I am sometimes hopeful, sometimes 
resigned”, and “From grieving to complete acceptance of the diagnosis of my child”. 
My feelings have not changed.  Parents (N = 19) reported that their feelings about their 
children’s diagnosis had not changed at all over time.  For example, parents’ responses included: 
“Not changed”, “Not really – there is no cure”, and “It’s still very recent, too hard to tell, very 
overwhelmed and sad still”.   
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More optimistic about child’s future now.  Parents (N = 15) also reported feeling more 
optimistic about their children’s futures than they had when their children were first diagnosed.  
For example, parents’ responses included: “From hopeless to extremely positive”, “More 
optimistic now”, and “I am more confident that my child will be successful in what he chooses 
for himself in life”.   
Better understanding of ASD now.  Parents (N = 12) reported that they now had a much 
better understanding of ASD than when their children were first diagnosed.  For example, 
parents’ responses included: “Complete understanding of the condition”, “Better understanding 
of the spectrum and influences and effects”, and “I feel more confident now; I know a lot more 
about ASD”.   
Describing ASD in a single word.  Parents (N = 110) responded to the fourth open-
ended survey item, which asked them to describe ASD in one word.  Since parents’ responses 
varied so widely and did not readily lend themselves to themes, these data are displayed in 
Figure 1. 
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Figure 1 
Parents’ Responses When Asked to Describe ASD in One Word 
 
*Note. Larger fonts indicate more frequently occurring words 
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Interview Question 1: Meaning of ASD to parents.  Parents (N = 10) who participated 
in the in-depth follow-up interview were asked to talk about what ASD meant to them.  The 
following themes were identified: 
Medical explanations.  Parents (N = 8) offered somewhat medicalized, scientific 
descriptions of ASD.  For example, parents’ responses included: “A very complex 
disorder…Underneath, there are genuine neurological problems” and “It’s a genetic condition”.   
A different way of seeing the world.  Parents (N = 4) reported viewing ASD as a different 
way of seeing the world.  For example, parents’ responses included: “A group of people who 
perceive the world differently through their emotions, mentally and physically, and in a sensory 
sense” and “Interacting with the world differently”.   
Not a tragedy – something that can be lived through.  (N = 4) Parents reported viewing a 
diagnosis of ASD not as a tragedy but as just another part of life.  For example, parents’ 
responses included: “It’s something that’s not going to be cured.  It’s not a death sentence.  It’s 
not as bad as people make it out to be” and “Nothing necessarily needs to be fixed, but worked 
with”.   
Pop culture view of ASD.  Parents (N = 2) offered descriptions of ASD that reflected 
representations of ASD in the media and popular culture.  For example, one parent responded, 
“My child is exactly like Sheldon from The Big Bang Theory…he says what’s on his mind, 
doesn’t understand why it’s not right to tell the truth when the truth will hurt people’s 
feelings…”. 
Interview Question 2: Factors influencing how parents think about ASD.  Parents (N 
= 10) who participated in the in-depth follow-up interview were asked to describe the factors that 
influence how they think about ASD.  The following themes were identified: 
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 Research, reading, and expert opinion.  Parents (N = 7) reported that their views of ASD 
were shaped in large part through reading ASD literature and hearing the views of experts in the 
field.  For example, parents’ responses included: “A lot of books and psychologists…a lot of 
research as well” and “Evidence-based research”.   
 Their own child.  Parents (N = 4) reported that their views of ASD were largely shaped 
by their experiences with their own child.  For example, one parent responded, “My personal 
experience with my son”.   
Interview Question 3: How parents define acceptance of their children’s ASD.  
Parents (N = 10) who participated in the in-depth follow-up interview were asked to describe 
what it means to accept one’s child’s diagnosis of ASD.  The following themes were identified: 
Having a balanced view of the child.  Parents (N = 5) described accepting a child’s 
diagnosis as maintaining a balanced view of the child and realizing that the child is unique and 
not necessarily sick.  For example, parents’ responses included: “Realizing that your child is 
unique in such a way that is not necessarily going to fit him into the cookie cutter mould that 
society has for children and teens” and “You don’t have to fix them.  They are who they are”.   
Consequences of not accepting a child’s diagnosis.  Parents (N = 5) also emphasized the 
consequences of not accepting the diagnosis, particularly for the child.  For example, one parent 
responded, “It’s one of the biggest factors in helping your child…If they can’t accept it then they 
are going to do a huge disservice and injustice to the child”.   
Not giving up on the child’s potential.  Parents (N = 4) conceptualized accepting one’s 
child’s diagnosis of ASD as understanding that the child has limitations, but maintaining an 
awareness of the child’s potential.  For example, one parent responded, “To accept their abilities 
and limitations, [although] I’m always pushing their limitations because you don’t want to  
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underestimate them”. 
End of grieving/mourning process.  Parents (N = 2) described accepting one’s child’s 
diagnosis of ASD as completing a process of grieving or mourning for the loss of their “hoped 
for” child.  For example, one parent responded, “There’s this mourning period where you have to 
accept that your life is never going to be what you thought it was going to be”.   
Interview Question 4: Factors influencing parents’ acceptance of their children’s 
ASD.  Parents (N = 10) who participated in the in-depth follow-up interview were asked to 
outline the factors that they felt influenced their acceptance of their children’s ASD.  The 
following themes were identified: 
Community support or barriers. Parents (N = 6) reported that members of their 
communities affected their acceptance of their children’s ASD.  Some parents reported that 
community members provided support to them, while others reported that community members 
acted as barriers to their acceptance of their children’s ASD.  For example, parents’ responses 
included: “We had a lot of support, which really helped…a lot of professional and family 
support” and “Some of our family members didn’t take it well and that’s hard”.   
Education.  Parents (N = 3) cited learning more about ASD as a major factor which 
influenced their acceptance of their children’s ASD.  For example, one parent responded, “The 
more we understand autism, we get a higher level of acceptance”.   
Receiving the diagnosis.  Parents (N = 3) reported that receiving the diagnosis of ASD 
from a professional increased their acceptance of their children’s ASD.  For example, one parent 
responded, “The diagnosis – having it confirmed by a professional who you trust”.   
Always accepted their child’s ASD.  Some parents (N = 2) reported having accepted their 
children’s ASD from their first suspicions.  For example, one parent responded, “We were the 
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ones who noticed something was amiss and then went looking for a diagnosis…I was able to 
give up being a ‘normal mother’ right from the get-go”.   
Interview Question 5: Parents’ challenges in selecting treatments for children with 
ASD.  Parents (N = 10) who participated in the in-depth follow-up interview were asked about 
their biggest challenges in selecting treatments for their children with ASD.  The following 
themes were identified: 
Knowing which treatments will work.  Parents (N = 5) reported experiencing challenges 
in knowing which treatments would be effective for their individual children.  For example, one 
parent responded, “Nothing works for every kid and it’s hard to figure out”.   
Forming positive relationships with professionals.  Parents (N = 4) reported 
experiencing difficulty forming positive working relationships with professionals involved in 
their children’s treatment plans. For example, parents’ responses included: “Being able to trust 
the service provider” and “Even though we had a diagnosis, the doctors pushed drugs”.   
Availability/location. Parents (N = 3) reported that the availability and location of 
treatments were challenging factors in their treatment selection.  For example, one parent 
responded, “Location and offering of treatment”.   
Looking into supporting research.  Parents (N = 3) reported that having to find and 
evaluate the empirical support behind each treatment was challenging during their treatment 
selection.  For example, one parent responded, “I read research…I wanted to know that scientific 
research was done on it”.   
Sense of responsibility and guilt.  Parents (N = 2) reported that experiencing feelings of 
responsibility and guilt in relation to their children made their treatment selection challenging.  
For example, one parent responded, “When you take on the responsibility for helping your child 
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and they aren’t getting better as fast as you want them to, there’s really no one to point a finger at 
but you”.   
Cost.  Parents (N = 2) reported that the cost associated with certain treatments was a 
major challenge for them throughout the process of treatment selection.  For example, one parent 
responded, “For us and everybody else, one of the biggest challenges is financial”. 
Interview Question 6: Advice for other parents selecting treatments for children 
with ASD.  Parents (N = 10) who participated in the in-depth follow-up interview were asked to 
outline their advice for future parents of children with ASD selecting treatments for their 
children.  The following themes were identified: 
Know the services.  Parents (N = 5) advised future parents to be knowledgeable about the 
services available in their area, currently being used by their children, and currently under study.  
For example, parents’ responses included: “Work with professionals that are in your child’s life” 
and “Make sure that you understand the services”.   
Accept your child’s diagnosis.  Parents (N = 3) advised future parents of children with 
ASD to quickly accept the diagnosis in order to begin selecting treatments as soon as possible.  
For example, parents’ responses included: “Stop trying to make them be something they’re not 
and accept them for who they are.  I think that will take a lot of pressure off the parents” and 
“Don’t be looking for something to cure your child.  There’s so many other options out there that 
you could be doing to help your child”.   
Pay attention to the research.  Parents (N = 3) advised future parents to consider the 
empirical support behind each treatment when selecting treatments for their children.  For 
example, one parent responded, “Research.  Make sure there is something behind it”.   
Trust your instincts.  Parents (N = 3) in the present study advised future parents to listen  
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to their instincts about which treatments will be best for their children, regardless of empirical or 
expert support.  For example, one parent responded, “If the things suggested to you don’t feel 
right or you really don’t think it’s going to work for your child, don’t do it”.   
Find a support system.  Parents (N = 2) in the present study advised future parents to 
cultivate a support system for themselves involving family, friends, and professionals.  For 
example, one parent responded, “Find a support group, find some friends that will listen to 
you…give you just that shoulder to lean on”.   
Be an advocate for your child. Parents (N = 2) advised other parents to take on the role 
of an advocate for their children in order to ensure that their children receive the best treatments 
possible.  For example, one parent responded, “In order to get help for your child, you have to be 
that voice they don’t have”.   
Additional comments.  Parents (N = 10) who participated in the in-depth follow-up 
interview were given the opportunity to voice any additional comments they had in regards to 
their conceptualizations of ASD, acceptance of ASD, or treatment selection for children with 
ASD.  One major theme evolved from these comments.   
Life goes on – children with ASD can accomplish so much.  Parents (N = 3) commented 
on the importance of not ruminating on their feelings of loss upon receiving their children’s 
diagnoses, but instead to maintain positivity and focus on supporting their children.  For 
example, parents’ responses included: “Don’t think your world is over because your child has 
Autism…their world is just beginning” and “Your child can do a lot more than people might 
think and the world might tell you”.    
PARENTS’ TREATMENT SELECTION  66 
Discussion 
 The purpose of the present study was to identify the relations between parents’ cognitive 
representations of their children’s ASD, acceptance of their children’s ASD, and treatment 
selection for their children.  Although some of the findings from the French study by Al Anbar, 
Dardennes, Prado-Netto, Kaye, and Contejean (2010) were replicated, many were not.  This 
comparison is explored in greater detail below. 
Review of Study Hypotheses 
Hypothesis I: Cognitive representations of ASD.  Results of the present study 
demonstrated that parents’ cognitive representations of their children’s ASD were significantly 
related to their treatment selection in certain specific ways. 
1a: Belief in consequences.  It was predicted that parents with stronger beliefs in the 
severity of ASD and its impact on various aspects of their child’s functioning would be more 
likely to select behavioural treatments for their children.  Results of the present study failed to 
support this association.  Parents with stronger beliefs in the severity of ASD and its impact on 
various aspects of their children’s functioning were not significantly more likely to select 
behavioural treatments for their children.   
1b: Belief in timeline.  It was predicted that parents with cognitive representations of 
ASD which include higher beliefs in a cyclical course of ASD symptomology would be more 
likely to select medication-based treatments for their children.  Results of the present study failed 
to support this association.  Parents with stronger beliefs in a cyclical course of ASD 
symptomology were not significantly more likely to select medication-based treatments for their 
children. 
1c: Belief in control.  It was predicted that parents with cognitive representations of ASD  
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which include higher beliefs in personal control over ASD would be less likely to select 
medication-based, special diets, and vitamin-based treatments for their children. Contrary to this 
prediction, the results of the present study indicated that parents with cognitive representations of 
ASD which include higher beliefs in personal control over ASD were more likely to select 
medication-based treatments for their children.  These stronger beliefs in one’s ability to control 
or cure one’s child with ASD may also be reflected qualitatively in the comments of parents who 
indicated that that their main goal for their children’s treatment was recovery.   
Through conducting post hoc, exploratory analyses, it was found that parents with the 
lowest levels of acceptance of their children’s ASD had stronger beliefs in their personal control 
over their children’s ASD than did parents with the highest levels of acceptance.  It makes 
intuitive sense that parents who feel they have a high degree of control over their children’s ASD 
experience lower levels of acceptance of their children’s diagnoses (perhaps even believing that 
they have the power to “cure” their children).  Medication-based treatments likely appeal to these 
parents because they operate under the assumption that the child’s ASD is caused by some type 
of chemical imbalance within the child which can be counteracted by the medication.     
Results of the present study failed to support the hypothesized relation between belief in 
personal control over ASD and selection of metabolic (i.e., special diets and vitamin-based) 
treatments.   
1d: Belief in external causes.  It was predicted that parents with stronger beliefs in 
external causes of their children’s ASD would be more likely to select metabolic treatments for 
their children.  Results of the present study supported this hypothesis.  This finding is consistent 
with previous findings by Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010), who 
found that parents with strong environmental causal attributions for their child’s ASD were more 
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likely to select nutritional and detoxification treatments for their children.  Qualitative data from 
the present study indicating that many parents struggle with feelings of responsibility and guilt 
over their children’s ASD and experience difficulty finding reliable information may also help to 
shed some light on this finding.  Parents who believe that an external factor such as receiving a 
vaccine cause their children’s ASD are likely more apt to experience feelings of guilt in relation 
to their children’s ASD.  Similarly, parents who experience greater difficulty accessing accurate 
information about the causes of ASD may be more likely to blame external factors such as 
vaccines for their children’s ASD. 
It is perhaps not surprising that parents who more strongly believed that their children’s 
ASD was caused by factors such as vaccine injury, altered immunity, and pollution in the 
environment were more likely to select special diet and vitamin-based treatments for their 
children.  These parents may be attempting to “counteract” the effects of the harmful stimuli 
which they believe caused their children to have ASD.   
1e: Negative emotional representations.  It was predicted that parents with more 
negative emotional reactions to the diagnosis of ASD would be less likely to select behavioural 
treatments for their children.  Results of the present study failed to support this association.  
Parents with more negative emotional reactions to their children’s ASD diagnoses were not 
significantly less likely to select behavioural treatments for their children. 
Hypothesis II: Acceptance of children’s ASD.  Since the majority of parents in the 
present study reported selecting at least one treatment within each NAC (2009) classification of 
empirical support (i.e., established, emerging, unestablished), it was not considered meaningful 
to search for associations between parents’ acceptance of their children’s ASD and their 
likelihood of selecting a treatment within each category of empirical support.  Instead, data were 
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examined to determine whether there were relations between parents’ acceptance of their 
children’s ASD and the number of treatments parents selected within each classification of 
empirical support.  
2a: High acceptance of ASD.  It was predicted that parents with higher levels of 
acceptance of their children’s ASD would report selecting more evidence-based treatments for 
their children.  Contrary to this prediction, the results of the present study indicated that parents 
with higher levels of acceptance of their children’s ASD reported selecting fewer evidence-based 
treatments for their children.  This result was not consistent with the conjectures of many 
researchers studying ASD (e.g., MacDonald, Hastings, & Fitzsimons, 2010; Mandell & Novak, 
2005; Siegel, 1997); however, this finding is an important advancement in better understanding 
parents’ treatment selection for their children with ASD.   
As suggested by the Parent Advisor for the present study after reviewing the qualitative 
results, parents with higher levels of acceptance of their children’s ASD may have a more 
holistic view of their children’s ASD.  That is, they may be more willing to recognize the 
positive aspects of their children’s ASD as well as the negative aspects, instead of 
conceptualizing their children’s ASD only in terms of symptoms needing to be alleviated.  
Therefore, instead of selecting a treatment for each symptom of ASD observed in their children, 
parents with higher levels of acceptance may select fewer treatments which they believe will 
improve their children’s overall functioning.  This notion of parental acceptance of ASD 
representing a more holistic view of the child with ASD is consistent with previous research by 
Mansell and Morris (2004) and Pianta, Marvin, Britner, and Borowitz (1996), indicating that 
parents with higher levels of acceptance of their child’s ASD diagnosis are better able to 
acknowledge their children’s strengths as well as challenges.   
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2b: Low acceptance of ASD.  It was predicted that parents with lower levels of 
acceptance of their children’s ASD would report selecting more non evidence-based treatments 
for their children.  Results of the present study supported this hypothesis.  This result may also 
be explained by the notion that parents with lower levels of acceptance of their children’s ASD 
may have more fragmented, symptom-focused conceptualizations of their children’s ASD.  It 
may be that their attempts to ameliorate each individual symptom of their children’s ASD leads 
them to select more treatments, on average, than parents with higher levels of acceptance who 
view their children’s ASD more holistically.  This would be consistent with previous research by 
Pianta, Marvin, Britner, and Borowitz (1996), which indicated that parents with low levels of 
acceptance of their children’s diagnoses of ASD are often confused about several aspects of the 
diagnosis and tend to have unbalanced beliefs about the consequences of the diagnosis.   
Although the finding that parents with lower levels of acceptance of their children’s ASD 
selected both more empirically supported treatments and more empirically unsupported 
treatments for their children may seem somewhat paradoxical, the result becomes clearer with 
further inspection.  What these results actually demonstrate is that parents with lower levels of 
acceptance select more treatments for their children in general than parents with higher levels of 
acceptance, regardless of empirical support.  In other words, it appears that parents with lower 
levels of acceptance of their children’s ASD take on a “shotgun approach” to treatment selection, 
whereby they try almost every treatment available with their children, regardless of the empirical 
support for the treatments.  Parents in the present study selected an average of 16 treatments, 
with 6 from the empirically “established” classification, 8 from empirically “emerging”, and 2 
from empirically “unestablished”.  This finding is consistent with results of a study by Call, 
Delfs, and Findley (2011) that parents report that they would ideally spread their time and 
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financial resources out over several (M = 40.8) treatments for their children with ASD.  Findings 
from an unpublished manuscript by Drouillard, Gragg, Miceli, and Voelker (2012) that the 
majority of parents of children with ASD believe that every treatment is effective in some way 
may also shed light on parents’ reasoning behind this “shotgun approach”.   
This “shotgun approach” to treatment selection can also be observed in people with 
serious illnesses such as cancer.  For example, results from a study by Richardson, Sanders, 
Palmer, Greisinger, and Singletary (2000) demonstrated that 83.3% of individuals with cancer 
reported having used at least one complementary/alternative medicine (CAM) treatment (e.g., 
spiritual practices, vitamins/herbs, special diets).  Even more interestingly, 24.7% of the 
participants (the largest group in their study) reported using seven or more CAM treatments.  In a 
similar study, 93.1% of individuals with cancer at the end of life reported using CAM treatments 
and use of CAM treatments was associated with longer time spent living with cancer, the 
presence of multiple types of cancer, and expectation of cure (Choi et al., 2012).  Although this 
latter study did not directly examine the number of CAMs used by each participant, the sum of 
the number of individuals who reported using each CAM (1093) was much greater than the 
sample size of the study (604), indicating that many participants reported selecting multiple 
CAMs.  When considered in light of these results, it appears that the “shotgun approach” to 
treatment selection may be associated with unrealistic hope of recovery or a sense of desperation 
in regard to one’s child’s ASD.   
Proposed Explanations for Discrepancies between Present and Past Research 
Although the present study had much in common with an earlier study conducted by Al 
Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010), there were several important 
differences which may help to account for the discrepant results. First, participants from the 
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present study most commonly reported living in the United States (45.2%) and Canada (25%), 
whereas all participants in the Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010) 
study lived in France.  According to these authors, parents of children with ASD in France often 
adopt a more psychological and less medical view of ASD, considering it to be more of a stable 
feature than an illness needing to be cured (Al Anbar, Dardennes, Prado-Netto, Kaye, & 
Contejean, 2010).  In the United States and Canada, a diagnosis of ASD is often seen as a 
“personal tragedy”, with parents of children with ASD experiencing significantly more despair 
and less hope for their children’s future than do parents of children with typical development 
(Hebert & Koulouglioti, 2010).   
It is also important to note that the healthcare systems in France and in Canada and the 
United States are likely very different.  As mentioned by parents in the present study, the cost 
associated with a particular treatment is often an important factor for parents when selecting 
treatments for their children with ASD.  The discrepant healthcare coverage for children with 
ASD in different countries, therefore, may have affected the results of the present study and 
helps to explain why results are somewhat inconsistent between the present study and Al Anbar, 
Dardennes, Prado-Netto, Kaye, and Contejean’s (2010) study. 
The children of participants in the Al Anbar, Dardennes, Prado-Netto, Kaye, and 
Contejean (2010) study were also older (M = 13.11 years) than children of participants in the 
present study (M = 8.83 years).  Although Al Anbar, Dardennes, Prado-Netto, Kaye, and 
Contejean (2010) found that the ages of children with ASD did not affect the types of treatments 
received, an American study by Goin-Kochel et al. (2007) found that younger children with ASD 
were more likely to receive behavioural treatments than were older children.  This study also 
found that older children with ASD were more likely to receive psychopharmacological 
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treatments than were younger children (Goin-Kochel et al., 2007).  It should be noted that the 
children in Goin-Kochel et al.’s (2007) study were much closer in age (M = 8.30 years) to 
children in the present study.  As also demonstrated in the exploratory quantitative findings of 
the present study, parents of younger children tend to try more treatments with their children than 
parents of older children, likely due to widespread recognition of the importance of early 
intervention.  As such, the large age difference between children in the Al Anbar, Dardennes, 
Prado-Netto, Kaye, and Contejean (2010) study and the present study likely accounts for some of 
the discrepancies in findings between the studies.  
An additional factor which may account for much of the discrepancy in results between 
the original Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010) study and the 
present study is that the original study presented participants with only a “short list of 
treatments” (pp. 1139) from which to indicate those they were currently using with their 
children.  In the present study, participants were presented with a list of 37 treatments in 
accordance with those reviewed in depth by the National Autism Center (2009).  This expanded 
list allowed participants to more accurately report the treatments they had selected for their 
children with ASD.  Participants in the present study were also asked to specify the treatments 
they had used with their child in the past, were currently using, or were on waitlists for.  This 
allowed for treatments which has been selected by parents for their children but which were not 
currently being used by their children to be accounted for in the present study.    
All participants in the present study completed the questionnaire online.  This differed 
significantly from participants in the study by Al Anbar, Dardennes, Prado-Netto, Kaye, and 
Contejean (2010) in which over half of the participants completed the questionnaire in pencil-
and-paper format in the presence of a researcher.  Although social desirability was not found to 
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be significantly associated with any of the variables of interest in the present study, it is possible 
that the in-person format of the Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010) 
study enhanced the influence of social desirability in their sample.  Since social desirability was 
not controlled for in the statistical analyses performed by Al Anbar, Dardennes, Prado-Netto, 
Kaye, and Contejean (2010), it is reasonable to hypothesize that this variable may also help to 
explain some of the discrepancy between the results in the original study and in the present 
study.    
Taken together, although the study by Al Anbar, Dardennes, Prado-Netto, Kaye, and 
Contejean (2010) was quite useful as an initial source of hypotheses for the present study, the 
differing sample of participants, treatment options, and questionnaire administration options of 
this study and the present study created many confounding variables which could not be 
accounted for in the statistical analyses conducted in the present study.  As such, follow-up 
research on the present study should utilize an integration of the exploratory quantitative and 
qualitative findings from this study to generate hypotheses which can more accurately be 
addressed by the data likely to be collected.    
Exploratory Quantitative Findings.   
Post hoc analyses of data from the present study revealed that, in addition to lower levels 
of acceptance, younger child age and living in the United States were associated with selecting a 
greater number of treatments for one’s child with ASD.  Parents of younger children with ASD 
may not have had a chance to fully come to terms with the implications (both for themselves and 
their children) of their children’s diagnoses.  It is also possible that this may be explained by a 
possible cohort effect for child age.  For example, the original paper by Andrew Wakefield and 
colleagues, in which it was suggested that the measles, mumps, and rubella (MMR) vaccine was 
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implicated in causing ASD, was published in 1998.  This paper was not retracted until 12 years 
later, in response to a ruling made by the UK General Medical Council’s Fitness to Practice 
Panel (Editors of the Lancet, 2010).  The treatment selection of many parents of children 
diagnosed with ASD after 1998, therefore, was likely affected by this highly publicized study.  
As shown in the present study, several parents of children with ASD continue to believe that 
their children’s ASD was caused by external factors (e.g., vaccine injury), despite the fact that 
this study has now been widely discredited.  Additionally, the predominance of the “medical 
model” of disability in the United States may lead parents living there to conceptualize ASD as 
an illness to be cured instead of a lifelong characteristic which can be improved through 
intensive intervention.  
Similarly, post hoc analyses revealed that lower levels of acceptance, older child age, 
older child age at diagnosis, greater time since diagnosis, lower levels of education, and 
identifying as White were associated with selection of empirically unsupported treatments for 
one’s child with ASD.  Again, it appears as though parents with lower levels of acceptance of 
their children’s ASD may not be as concerned with the empirical support behind each treatment 
as they are with the purported benefits of each treatment.  It generates some hope, however, to 
note that parents of younger and more recently diagnosed children appear to be more likely to 
select empirically supported treatments than parents of older and less recently diagnosed 
children.  Perhaps public knowledge of the limitations of the original Wakefield et al. (1998) 
study, as well as of the various well-established treatments available for children with ASD, is 
increasing over time.   
Post hoc analyses also revealed that low levels of acceptance of one’s child’s ASD were 
associated with stronger beliefs in personal control over one’s child’s ASD, lower levels of 
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education, living in the United States, and identifying as White.  It may be that the more 
medicalized view of ASD in North America as opposed to other regions yields lower levels of 
acceptance of individuals’ disabilities and, instead, favours a more problem-focused approach to 
disability.  Individuals with lower levels of education may be less likely to challenge these 
views, resulting in lower levels of acceptance of ASD among these individuals. 
Additionally, post hoc analyses revealed that more negative reactions to one’s child’s 
diagnosis of ASD were associated with greater beliefs in external causes of one’s child’s ASD 
(e.g., vaccine injury, pollution in the environment).  In other words, it appears that parents who 
believe that their children were born “typical” but, through some event or stimulus, developed 
ASD have lower levels of acceptance of their children’s ASD.  This is consistent with research 
by Pianta, Marvin, Britner, and Borowitz (1996), which demonstrated that parents who had not 
achieved acceptance of their children’s ASD were overly focused on the causes of their 
children’s ASD.   
Somewhat surprisingly, more negative emotional reactions to one’s child’s diagnosis of 
ASD were also found to be associated with higher levels of acceptance.  Although this may 
initially seem counterintuitive, it makes sense when we recall that the AAQ-II-A actually 
measures parents’ willingness to experience uncomfortable thoughts and emotions related to 
one’s child’s ASD in order to achieve a certain goal (e.g., selecting a high-quality treatment for 
one’s child).  It appears that parents with lower levels of acceptance of their children’s ASD may 
not allow themselves to fully experience the uncomfortable thoughts and emotions which 
naturally arise after receiving the diagnosis of ASD.   
An unexpected correlation was also found between the number of evidence-based 
treatments and the number of non evidence-based treatments selected by parents.  More 
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specifically, parents who selected more evidence-based treatments for their children with ASD 
also reported selecting more non evidence-based treatments for their children with ASD.  This 
was the strongest relation found in the present study.    It appears that, although lower levels of 
acceptance of one’s child’s ASD are associated with selecting more evidence-based and non 
evidence-based treatments for one’s child, a stronger predictor of the number of non evidence-
based treatments selected is the number of evidence-based treatments selected.  A significant 
number of parents seem to be selecting “whatever treatments they can get” for their children, 
regardless of the empirical support behind each individual treatment.  This inference is also 
supported by the finding that, of the five treatments parents most commonly reported selecting, 
three (i.e., antecedent package, behavioural package, and schedules) were classified as 
empirically “established” and two (i.e., academic interventions and gluten/casein-free diet) were 
classified as empirically “unestablished”.  As previously discussed, this “shotgun approach” to 
treatment selection may be associated with a sense of desperation and unrealistic hope of 
recovery for one’s child’s ASD.   When considered in light of qualitative findings from the 
present study, the “shotgun approach” to treatment selection may also be associated with a more 
compartmentalized or symptom-focused conceptualization of ASD.  Individuals with this view 
may consider each symptom of ASD separately and select a treatment which they believe will 
help ameliorate that specific symptom.  These parents likely also have lower levels of acceptance 
as they may have not yet integrated the various aspects of the diagnosis of ASD into one 
inclusive conceptualization. 
Exploratory Qualitative Findings 
 Thematic analysis of qualitative data from the present study was conducted on a 
question-by-question basis with the assistance of the parent advisor and the research supervisor 
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for the study.  For the purposes of the discussion, however, the overarching themes from 
responses to the open-ended questions will be examined in greater detail below.   
Conceptualizations of ASD.  Parents in the present study appeared to hold dichotomous 
views in relation to their children’s ASD.  An overarching theme representing one of these 
viewpoints is that children with ASD do not need to be “fixed” or forced to blend in with 
children with typical development.  This sentiment is reflected in one mother’s definition of 
acceptance of her child’s diagnosis, “Realizing that your child is unique in such a way that is not 
necessarily going to fit him into the cookie cutter mould that society has for children and teens”. 
Alternatively, another overarching theme which emerged through parents’ responses to 
the open-ended questions is that many parents wish for their children with ASD to be “normal” 
and no longer show symptoms of ASD.  This desire was reflected in the words of one parent who 
reported that her biggest goal in her child’s intervention was for her child to achieve “complete 
indistinguishability from same-age peers” and another parent who reported that her goal for her 
child’s treatment was for her child to achieve “complete recovery”.   
These divergent views may provide further evidence for the notion that parents with 
higher levels of acceptance of their children’s ASD may view their children more holistically, 
while parents with lower levels of acceptance of their children’s ASD may have more 
fragmented, symptom-focused views of their child.  For example, when asked about their 
ultimate goal for their child’s intervention program, several parents offered symptom-focused 
responses such as “Verbal, appropriate communication, social interactions, and significant 
reduction in sensory processing issues”.  When asked the same question, however, several other 
parents offered more holistic responses such as “For her to be the best her she can be”.  It may be 
that the former parent had a higher level of acceptance of his/her child’s ASD than the latter 
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parent.  Consistent with previous findings that parents’ acceptance of their children’s ASD does 
not necessarily increase over time (e.g., Milshtein, Yirmiya, Oppenheim, Koren-Karie, & Levi, 
2010), the same parents sometimes offered statements reflecting both sides of this dichotomy in 
response to different questions. 
Treatment selection.  Parents in the present study reported that several factors were 
influential in their treatment selection for their children with ASD.  The importance of practical 
considerations when selecting treatments was a repeated theme throughout parents’ responses to 
the open-ended items.  Of these practical considerations, the cost and availability of treatments in 
their community were the most frequently mentioned.  This theme was reflected in the words of 
one parent who asserted that “for us and everybody else, one of the biggest challenges [to 
selecting treatments] is financial” and another parent who admitted that one of the most 
significant challenges she faced when selecting treatments for her child with ASD was the 
“location and offering of treatment”. 
Besides practical considerations, an additional overarching theme in parents’ responses 
was the reported importance placed on empirical support for treatments by parents of children 
with ASD.  Nearly all parents in the present study reported considering empirical support when 
selecting treatments for their children with ASD.  For example, one parent described his 
treatment selection process, saying “My methods are more research based…I read research…I 
wanted to know that scientific research was done on it”, while another parent advised future 
parents of children with ASD selecting treatments for their children to “research. Make sure  
there is something behind it”.   
This finding is interesting when considered in conjunction with other results from the 
present study demonstrating that, on average, parents reported selecting 5.76 treatments 
PARENTS’ TREATMENT SELECTION  80 
classified as empirically “established”, 7.94 treatments classified as empirically “emerging”, and 
2.52 treatments classified as empirically “unestablished”.  It appears that, although parents report 
that empirical support is important to them when selecting treatments for their children with 
ASD, their actual treatment selection is not consistent with these reports.  One possible 
explanation for this discrepancy is that parents may not always fully understand what is meant by 
“empirical support” for a given treatment or where this information is available.  This 
explanation is consistent with previous findings from an unpublished manuscript by Drouillard, 
Gragg, Miceli, and Voelker (2012) demonstrating that parents of children with ASD often do not 
independently read scientific journal articles to ascertain information about the empirical support 
for various proposed treatments.  Instead, they frequently report relying on healthcare 
professionals, the internet, community ASD organizations, and other parents of children with 
ASD for information on the empirical support for various treatments.  Unfortunately, these 
sources may not always offer valid and reliable information to parents, which may lead many 
parents to unknowingly select empirically unsupported treatments for their children.   
An additional overarching theme may also help shed light on this discrepancy between 
parents’ reported and actual emphasis on empirical support for proposed treatments for ASD.  
Parents’ responses to several open-ended questions formed an overarching theme of listening to 
their instincts or “gut feelings” when selecting treatments for their children with ASD.  
Furthermore, several parents admitted to placing more importance on their parental instincts than 
on professional recommendations or empirical support when selecting treatments for their 
children.  In the words of one mother, “The experts don’t really know any better than you do. 
They can just give you options and say ‘Here’s what available and what has worked for other 
people’, but only you as a parent know for sure”.  In this sense, parents may be considering 
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empirical support when selecting treatments for their children with ASD, but simultaneously 
placing more importance on their own instincts about which treatments will be most effective 
and the “best fit” for their children. 
 Finally, an overarching theme of the importance of supportive relationships for parents of 
children with ASD emerged throughout parents’ responses to several open-ended questions.  
Parents in the present study spoke of the importance of social support in a variety of contexts, 
such as when coming to terms with their children’s diagnoses and when selecting treatments for 
their children.  Parents also emphasized the importance of positive relationships not only within 
the immediate family, but also within the extended family, with friends, with other parents of 
children with ASD, and with professionals working with the child and family.  For example, 
when asked to offer their advice to future parents of children with ASD, one parent replied “Talk 
to other parents… when you speak to other parents you hear stories and what their thoughts are 
and all that and that kind of makes it more real so it also gives yourself support”, while another 
parent advised future parents to “work with professionals that are in your child’s life…with your 
pediatrician, with the school counselor, the teacher ‘cause they see your child…in a light that 
you don’t”. 
 Several parents also spoke of the negative consequences of not having a system of social 
support in place.  As one mother recalled, “Some of our family members didn’t take [the 
diagnosis] well and that’s hard”.  Many parents also recalled receiving little support from 
professionals working with their children.  For example, one mother asserted that “the hardest 
challenge is that…the doctors pushed drugs”, while another parent confessed “Sometimes I also 
have a lot of frustration with each doctor telling me I’m wrong when I know that I’m not and I 
can see my child getting better”.   
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Limitations of the Present Study   
Recruitment for the present study largely took place online through ASD-related listservs 
and organizations.  Although many of these organizations were for parents of children with ASD 
in general (e.g., Autism Ontario), many of them were also for parents of children with ASD 
interested in particular treatments for ASD or proposed causes of ASD (e.g., GFCFkids, 
medicaidforhbot, VacInfoCoalition).  Many of the groups with the largest online presence 
represented non-mainstream opinions in terms of recommended treatments and proposed causes 
of ASD.  Therefore, individuals with these opinions may have been overrepresented in the 
present sample.  Additionally, 75% of participants in the study reported having graduated from 
college or university.  Parents with high levels of education, then, were overrepresented in the 
sample and the study findings may be less generalizable to parents who have not graduated from 
college or university.   
Some of the data collected in the present study were retrospective (e.g., recalling the 
length of time parents had used certain treatments with their children).  This method may have 
compromised the accuracy of the data in some cases, particularly for parents of older children 
who may have had to recall treatments used over a decade ago with their child.  A related 
limitation of the present study is that several parents did not respond to demographic 
questionnaire items which asked about when they had used each treatment with their child (in the 
past, presently, or future [waitlisted]).   Due to this, data about the length of time each treatment 
was used with each child could not be examined in the present study. 
Parents in the present study were also recruited from diverse geographic locations, mostly 
in the U.S., Canada and Australia.  This diverse sampling was necessary to accumulate a large 
enough sample of parents, but prohibits results of the present study from generalizing to a 
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specific group of parents of children with ASD.  Also, since parents of children up to the age of 
21 participated in the present study, findings do not necessarily apply to parents’ treatment 
selection for their children with ASD of certain specific ages.   
Strengths of the Present Study 
Despite the limitations of the present study, there were also many positive aspects and 
improvements on previous research.  The present study addressed the limitations of Al Anbar, 
Dardennes, Prado-Netto, Kaye, and Contejean’s (2010) study by modifying the IPQ-R (Moss-
Morris et al., 2002) to include ASD-specific symptoms as outlined in the DSM-IV-TR (APA, 
2000).  The present study also included an expanded list of 37 treatments which allowed parents 
to indicate those they were currently using with their children as well as past and planned 
treatments.  Finally, the present study addressed another limitation of the original study by Al 
Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010) by revising the Causes subscale of 
the IPQ-R to include ASD-specific causes taken from Furnham and Buck’s (2003) Lay Beliefs 
about Autism Questionnaire (as has been done by Dardennes, Al Anbar, Prado-Netto, Kaye, 
Contejean, and Al Anbar [2011]) as well as additional causes popularly cited by parents of 
children with ASD. 
The present study was the first to empirically examine the relations between parents’ 
acceptance of their children’s ASD and their treatment selection for their children.  With ASD 
researchers long alluding to a possible relation between these constructs, findings taken from the 
present study add to the knowledge currently available in the literature.  Professionals can use 
their knowledge of this established relation between parents’ acceptance of their children’s ASD 
and their treatment selection for their children to help foster acceptance from the original 
diagnosis of ASD.  
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As associations between parents’ cognitive representations of their children’s ASD and 
their treatment selection have only recently begun to be studied, an additional strength of the 
present study was that it incorporated several exploratory open-ended questions for qualitative 
analysis.  The findings from these qualitative analyses add a richness to the results of the present 
study and help readers to interpret quantitative results in a manner which more accurately reflects 
the opinions of parents of children with ASD.  The participatory action research framework 
utilized in the present study also helped to ensure that the goals, methods, results, and 
conclusions of the study were relevant, responsible, and helpful to parents of children with ASD.   
Implications and Future Study 
Findings from the present study significantly contribute to our knowledge of factors 
influencing parents’ treatment selection for their children with ASD and have important 
implications for professionals working with parents of children with ASD.  Results of the present 
study suggest that parents with low levels of acceptance of their children’s ASD often appear to 
employ a “shotgun approach” to treatment selection, whereby they try nearly every treatment 
available with their children.  This means that parents with lower levels of acceptance of their 
children’s ASD generally select more treatments for their children and, perhaps more 
importantly, select more empirically unsupported treatments for their children with ASD.  
Furthermore, this “shotgun approach” also appears to be utilized by individuals with cancer who 
hope for complete recovery, particularly those approaching the end of life or who have multiple 
types of cancer (e.g., Choi et al., 2012).  The parents who employed a “shotgun approach” to 
treatment selection in the present study may be similar to these individuals with cancer, selecting 
many treatments for their children in the hopes that one of them will be effective in returning 
their children to “normal”.   
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Workshops focusing on increasing parents’ acceptance of their children’s ASD through 
interventions such as Acceptance and Commitment Therapy (e.g., Blackledge & Hayes, 2006) 
may therefore be beneficial, especially for parents of newly diagnosed children, in terms of 
increasing selection of empirically supported treatments and reducing parents’ likelihood of 
selecting empirically unsupported treatments for their children with ASD.  Future studies should 
evaluate the efficacy of acceptance-focused interventions for the specific purpose of reducing 
parents’ selection of unsupported treatments for their children with ASD. 
Results of the present study also provide some support for the application of the self-
regulation model of illness behaviour (Leventhal, Leventhal, & Contrada, 1999; Leventhal, 
Meyer, & Nerenz, 1980) to parents of children with ASD.  In the present study, the dimensions 
of the model significantly associated with parents’ treatment selection for their children with 
ASD were control/cure and cause.  Parents’ beliefs about their degree of control over their 
children’s ASD was the strongest identified predictor of their treatment selection (i.e., high 
beliefs in personal control over one’s child’s ASD predicted selection of medication-based 
treatments), while parents’ beliefs about the cause of their children’s ASD were also associated 
with their treatment selection (i.e., high beliefs in external causes predicted selection of 
metabolic treatments). 
Although parents’ acceptance and cognitive representations of their children’s ASD 
affected their treatment selection for their children, several other factors are also important to 
consider.  Of particular importance are practical considerations such as the cost and availability 
of each treatment within the local community; support or lack of support from family, friends, 
other parents, and professionals; empirical support for each treatment; and parents’ “gut 
feelings” about each treatment.  Although treatment constraints due to high cost and lack of 
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availability in many areas are unfortunate realities for many parents of children with ASD, 
factors such as social support and parents’ “gut feelings” about ASD treatments are likely much 
more amenable to change.  Parents’ instincts are valuable and should certainly not be ignored or 
minimized by professionals; however, professionals may use this knowledge to collaborate with 
parents when selecting treatments, ensuring that the knowledge they base their decisions on is 
accurate.  Future research examining the effectiveness of community education seminars and 
workshops promoting the importance of these factors in terms of their influence on the quality of 
treatments received by children with ASD would be beneficial.   
Finally, results of the present study also demonstrated that, although most parents report 
that empirical support is an important factor in their treatment selection for their children with 
ASD, parents’ actual treatment choices do not consistently reflect this claim.  This finding 
implies that there is a significant disconnect between research and parents of children with ASD.  
It may be that parents of children with ASD do not know where to find reliable information 
about the empirical support for various treatments, have difficulty understanding the scientific 
literature, or are not aware that the sources of information they most commonly report using (i.e., 
healthcare professionals, the internet, community ASD organizations, and other parents of 
children with ASD; Drouillard, Gragg, Miceli, & Voelker, [2012]) are not always reliable.  
Future research focusing on better understanding the reasons behind this disconnect between 
research and parents, and how to bridge the gap, would likely be beneficial in terms of helping 
more parents of children with ASD select empirically supported treatments for their children.   
Conclusions 
 Overall, results from the present study suggest that parents’ treatment selection for their 
children with ASD is a complicated process with many influences.  Many factors which were 
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found to be associated with parents’ treatment selection (e.g., parents’ beliefs about the causes of 
their child’s ASD, parents’ beliefs about the empirical support behind proposed treatments) were 
often found to be based on inaccurate or unsupported claims.  This tendency often leads many 
well-intentioned parents to unknowingly select empirically unsupported, or even potentially 
harmful, treatments for their children with ASD.  Additionally, low levels of acceptance of one’s 
child’s diagnosis of ASD was demonstrated to be associated with a “shotgun approach” to 
treatment selection, involving selecting significantly more treatments – regardless of empirical 
support – than parents with higher levels of acceptance.  Parent-focused programs aiming to 
increase parents’ knowledge of ASD, its causes, and the evidence behind various proposed 
treatments, in addition to programs aiming to increase parents’ acceptance of their children’s 
diagnoses of ASD, would likely be beneficial in terms of increasing the likelihood of children 
with ASD receiving evidence-based interventions. 
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Appendix A: Complete List of ASD-Related Organizations and Listervs used for 
Recruiting 
ASD-Related Organizations 
Summit Centre Preschool for Children with Autism 
Autism Ontario, Windsor-Essex Chapter 
Autism Ontario 
Autism Services Incorporated of Windsor and Essex County  
St. Mary's Family Learning Centre 
Potential Program, Windsor-Essex Chapter  
Potential Program, Hamilton Chapter 
Autism Ontario, Chatham-Kent Chapter 
Autism Ontario, Durham Chapter 
Autism Ontario, Grey Bruce Chapter 
Autism Ontario, Halton Chapter 
Autism Ontario, Huron-Perth Chapter 
Autism Ontario, Kingston Chapter 
Autism Ontario, London Chapter 
Autism Ontario, Niagara Chapter 
Autism Ontario, North Bay Chapter 
Autism Ontario, Ottawa Chapter 
Autism Ontario, Peel Chapter 
Autism Ontario, Peterborough Chapter 
Autism Ontario, Sault Ste. Marie Chapter 
Autism Ontario, Sudbury Chapter 
Autism Ontario, Toronto Chapter 
Autism Ontario, Cornwall Chapter 
Autism Ontario, Waterloo Chapter 
Autism Ontario, Wellington Chapter 





Autism Society of Greater Tucson 
Parents of Autism UK 
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Appendix B: Demographic Questionnaire 
Please let us know a bit about yourself. 
1. Your Gender: a)  Male b)  Female 
2. Your Age: a)  18-34 years     b)  35-44     c)  45-54     d)  55-64     e)  65+ 
3. Your Marital Status:  4. Your Household Income: 
a)  Single  a)  Under $25,000 
b)  Married and Living with partner  b)  $25,000 - $49,999 
c)  Separated  c)  $50,000 - $74,999 
d)  Divorced  d)  $75,000 and Over 
5. Your Education:   6. Employment Status: 
a)  High School or Less                                        You:                                   Your Spouse/Partner:  
b)  Some College a)  Full-Time a)  Full-Time 
c)  College or Post-Graduate b)  Part-Time   b)  Part-Time 
       c)  Unemployed c)  Unemployed 
                                              d)  Retired d)  Retired 
 
7. Child’s birthday: month (a) ______ & year (b): _____    
8. Is your child (a)  a boy?  or (b)  a girl? 
9. Child’s birthplace:  
City/town (a): _________, province/state (b): ______________, country (c): _______________ 
10. Your current city/town of residence:  
City/town (a):_______________, province/state (b):____________, country (c):__________________ 
11. Your relationship to your child:  
a)  birth parent    b)  other caregiver (adoptive/foster parent, grandparent, etc.) 
12. Child’s age at diagnosis: My child was ______ months old when diagnosed with autism. 
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13. Time since child’s diagnosis: It has been _____ months since my child was diagnosed with autism. 
14. Which race or ethnicity do you identify with the most for yourself and for your child?  
(Check one in both columns) 
Race or Ethnicity a) You b) Your Child 
a) Aboriginal   
b) Arab   
c) Black   
d) Chinese   
e) Filipino    
f) Japanese   
g) Korean   
h) Latin American   
i) South Asian (East Indian, Pakistani, Sri Lankan, etc.)   
j) Southeast Asian (Cambodian, Indonesian, Laotian, 
Vietnamese, etc.) 
  
k) West Asian (Afghan, Iranian, etc.)   
l) White   
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15.  What treatments for ASD has your child had?  
Please check whether each treatment was used in the past (not currently using), is presently being used, 
or will be used in the future (currently waitlisted) and indicate the number of months your child 
participated in each treatment (if applicable).    
 





a) Academic interventions 
These interventions are designed to teach 
individuals with ASD to recognize and identify 
mental states (i.e., a person’s thoughts, beliefs, 
intentions, desires and emotions) in oneself or in 
others and to be able to take the perspective of 
another person in order to predict their actions. 
    
 
b) Antecedent package 
These interventions involve the modification of 
situational events that typically precede the 
occurrence of a target behavior. These 
alterations are made to increase the likelihood of 
success or reduce the likelihood of problems 
occurring. Treatments falling into this category 
reflect research representing the fields of 
applied behavior analysis (ABA), behavioral 
psychology, and positive behavior supports. 
    
 
c) Auditory integration training 
This intervention involves the presentation of 
modulated sounds through headphones in an 
attempt to retrain an individual’s auditory 
system with the goal of improving distortions in 
hearing or sensitivities to sound. 




These interventions involved the use of high or 
low technologically sophisticated devices to 
facilitate communication. Examples include but 
are not restricted to: pictures, photographs, 
symbols, communication books, computers, or 
other electronic devices. 
    
 
e) Behavioural package 
These interventions are designed to reduce 
problem behavior and teach functional 
alternative behaviors or skills through the 
application of basic principles of behavior 
change. Treatments falling into this category 
    
PARENTS’ TREATMENT SELECTION  109 
reflect research representing the fields of 
applied behavior analysis, behavioral 
psychology,and positive behavior supports. 
 
f) Cognitive behavioural intervention 
package 
These interventions focus on changing everyday 
negative or unrealistic thought patterns and 
behaviors with the aim of positively influencing 
emotions and/or life functioning. 
    
 
g) Comprehensive behavioural treatment 
for young children 
This treatment reflects research from 
comprehensive treatment programs that involve 
a combination of applied behavior analytic 
procedures (e.g., discretetrial, incidental 
teaching, etc.) which are delivered to young 
children (generally under the age of 8). These 
treatment programs may also be referred to as 
ABA programs or behavioral inclusive program 
and early intensive behavioral intervention. 
    
 
h) Developmental relationship-based 
treatment 
These treatments involve a combination of 
procedures that are based on developmental 
theory and emphasize the importance of 
building social relationships. These treatment 
programs may also be referred to as the Denver 
Model, DIR (Developmental, Individual 
Differences, Relationship-based)/Floortime, 
Relationship Development Intervention, or 
Responsive Teaching. 
    
 
i) Exercise 
These interventions involve an increase in 
physical exertion as a means of reducing 
problems behaviors or increasing appropriate 
behavior. 
    
 
j) Exposure package 
These interventions require that the individual 
with ASD increasingly face anxiety-provoking 
situations while preventing the use of 
maladaptive strategies used in the past under 
these conditions. 
    
 
k) Facilitated communication 
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This intervention involves having a facilitator 
support the hand or arm of an individual with 
limited communication skills, helping the 
individual express words, sentences, or 
complete thoughts by using a keyboard of words 
or pictures or typing device.  
 
l) Gluten/casein-free diet 
These interventions involve elimination of an 
individual’s intake of naturally occurring 
proteins gluten and casein. 
    
 
m) Imitation-based interaction 
These interventions rely on adults imitating the 
actions of a child. 
    
 
n) Initiation training 
These interventions involve directly teaching 
individuals with ASD to initiate interactions 
with their peers. 
    
 
o) Joint attention intervention 
These interventions involve building 
foundational skills involved in regulating the 
behaviors of others. Joint attention often 
involves teaching a child to respond to the 
nonverbal social bids of others or to initiate joint 
attention interactions. 
    
 
p) Language training (production) 
These interventions have as their primary goal 
to increase speech production. Examples include 
but are not restricted to: echo relevant word 
training, oral communication training, oral 
verbal communication training, structured 
discourse, simultaneous communication, and 
individualized language remediation. 
    
 
q) Language training (production and 
understanding) 
These interventions have as their primary goals 
to increase both speech production and 
understanding of communicative acts. Examples 
include but are not restricted to: total 
communication training, position object 
training, position self-training, and language 
programming strategies. 
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r) Massage/touch therapy 
These interventions involve the provision of 
deep tissue stimulation. 
 
s) Modeling 
These interventions rely on an adult or peer 
providing a demonstration of the target behavior 
that should result in an imitation of the target 
behavior by the individual with ASD. Examples 
include live modeling and video modeling. 
    
 
t) Multi-component package 
These interventions involve a combination of 
multiple treatment procedures that are derived 
from different fields of interest or different 
theoretical orientations. These treatments do not 
better fit one of the other treatment “packages” 
in this list nor are they associated with specific 
treatment programs. 
    
 
u) Music therapy 
These interventions seek to teach individual 
skills or goals through music. A targeted skill 
(e.g., counting, learning colors, taking turns, 
etc.) is first presented through song or rhythmic 
cuing and music is eventually faded. 
    
 
v) Naturalistic teaching strategies 
These interventions involve using primarily 
child-directed interactions to teach functional 
skills in the natural environment. These 
interventions often involve providing a 
stimulating environment, modeling how to play, 
encouraging conversation, providing choices 
and direct/natural reinforcers, and rewarding 
reasonable attempts. 
    
 
w) Peer-mediated instructional 
arrangement 
These interventions involve targeting academic 
skills by involving same-aged peers in the 
learning process. This approach is also 
described as peer tutoring.  
    
 
x) Peer training package 
These interventions involve teaching children 
without disabilities strategies for facilitating 
play and social interactions with children on the 
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autism spectrum. Peers may often include 
classmates or siblings. Common names for 
intervention strategies include peer networks, 
circle of friends, buddy skills package, 
Integrated Play Groups™, peer initiation 
training, and peer-mediated social interactions. 
 
y) Picture exchange communication 
system 
This treatment involves the application of a 
specific augmentative and alternative 
communication system based on behavioral 
principles that are designed to teach functional 
communication to children with limited verbal 
and/or communication skills. 
    
 
z) Pivotal response treatment 
This treatment is also referred to as PRT, 
Pivotal Response Teaching, and Pivotal 
Response Training. PRT focuses on targeting 
“pivotal” behavioural areas — such as 
motivation to engage in social communication, 
self-initiation, self-management, and 
responsiveness to multiple cues, with the 
development of these areas having the goal of 
very widespread and fluently integrated 
collateral improvements. 
    
 
aa) Reductive package 
These interventions rely on strategies designed 
to reduce problem behaviors in the absence of 
increasing alternative appropriate behaviors. 
Examples include but are not restricted to water 
mist, behavior chain interruption (without 
attempting to increase an appropriate behavior), 
protective equipment, and ammonia. 
    
 
bb) Schedules 
These interventions involve the presentation of a 
task list that communicates a series of activities 
or steps required to complete a specific activity. 
Schedules can take several forms including 
written words, pictures or photographs, or work 
stations. 
    
 
cc) Scripting 
These interventions involve developing a verbal 
and/or written script about a specific skill or 
situation which serves as a model for the child 
with ASD. Scripts are usually practiced 
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repeatedly before the skill is used in the actual 
situation. 
 
dd) Self management 
These interventions involve promoting 
independence by teaching individuals with ASD 
to regulate their behavior by recording the 
occurrence/non-occurrence of the target 
behavior, and securing reinforcement for doing 
so. Examples include the use of checklists 
(using checks, smiley/frowning faces), wrist 
counters, visual prompts, and tokens. 
    
 
ee) Sensory integrative package 
These treatments involve establishing an 
environment that stimulates or challenges the 
individual to effectively use all of their senses as 
a means of addressing overstimulation or 
understimulation from the environment. 
    
 
ff) Sign instruction 
These interventions involve the direct teaching 
of sign language as a means of communicating 
with other individuals in the environment. 
    
 
gg) Social communication intervention 
These psychosocial interventions involve 
targeting some combination of social 
communication impairments such as pragmatic 
communication skills, and the inability to 
successfully read social situations. These 
treatments may also be referred to as social 
pragmatic interventions. 
    
 
hh) Social skills package 
These interventions seek to build social 
interaction skills in children with ASD by 
targeting basic responses (e.g., eye contact, 
name response) to complex social skills (e.g., 
how to initiate or maintain a conversation). 
    
 
ii) Story-based intervention package 
These treatments involve a written description 
of the situations under which specific behaviors 
are expected to occur. Social Stories™ are the 
most well-known story-based interventions and 
they seek to answer the “who,” “what,” “when,” 
“where,” and “why” in order to improve 
perspective-taking. 
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jj) Structured teaching 
Based on neuropsychological characteristics of 
individuals with autism, this intervention 
involves a combination of procedures that rely 
heavily on the physical organization of a setting, 
predictable schedules, and individualized use of 
teaching methods. These treatment programs 
may also be referred to as TEACCH (Treatment 
and Education of Autistic and related 
Communication-handicapped CHildren). 
    
 
kk) Technology-based treatment 
These interventions require the presentation of 
instructional materials using the medium of 
computers or related technologies. Examples 
include but are not restricted to Alpha Program, 
Delta Messages, the Emotion Trainer Computer 
Program, pager, robot, or a PDA (Personal 
Digital Assistant). 
    
 
ll) Theory of mind training 
These interventions are designed to teach 
individuals with ASD to recognize and identify 
mental states (i.e., a person’s thoughts, beliefs, 
intentions, desires and emotions) in oneself or in 
others and to be able to take the perspective of 
another person in order to predict their actions. 
    
 
mm) Other (please specify): 
_______________________________ 
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Appendix D: IPQ-RA-E 
Your views about your child’s Autism: 
 
Listed below are a number of symptoms that you may or may not have observed in your child with 
Autism.  Please indicate by ticking Yes or No whether you have observed any of these symptoms in 
your child, and whether you believe that these symptoms are related to your child’s Autism. 
 
Symptom 
My child has 
experienced this 




This symptom is 
related to my child’s 
Autism 
Yes No Yes No 
1. Marked impairment in the use of multiple 
nonverbal behaviours such as eye-to-eye 
gaze, facial expression, body postures, and 
gestures to regulate social interaction 
    
2. Failure to develop peer relationships 
appropriate to developmental level 
    
3. A lack of spontaneous seeking to share 
enjoyment, interests, or achievements with 
other people (e.g., by a lack of showing, 
bringing, or pointing out objects of interest) 
    
4. Lack of social or emotional reciprocity     
5. Delay in, or total lack of, the development 
of spoken language (not accompanied by an 
attempt to compensate through alternative 
modes of communication such as gesture or 
mime) 
    
6. Marked impairment in the ability to initiate 
or sustain a conversation with others 
    
7. Stereotyped and repetitive use of language 
or idiosyncratic language 
    
8. Lack of varied, spontaneous make-believe 
play or social imitative play appropriate to 
developmental level 
    
9. Encompassing preoccupation with one or 
more stereotyped and restricted patterns of 
interest that is abnormal either in intensity 
or focus 
    
10. Apparently inflexible adherence to specific, 
nonfunctional routines or rituals 
    
11. Stereotyped and repetitive motor 
mannerisms (e.g., hand or finger flapping or 
twisting, or complex whole-body 
movements) 
    
12. Persistent preoccupation with parts of 
objects 
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We are interested in your personal views of how you now see your child’s Autism.  Please indicate 
how much you agree or disagree with the following statements about your child’s Autism by ticking 
the appropriate box. 
 
  

















My child’s Autism will last a 
short time. 
     
2
2. 
My child’s Autism is likely to be 
permanent rather than temporary. 
     
3
3. 
My child’s Autism will last for a 
long time. 
     
4
4. 
My child’s Autism will pass 
quickly. 
     
5
5. 
I expect my child to have Autism 
for the rest of his/her life. 
     
6. Autism is a serious disorder.      
 
7. 
My child’s Autism has major 
consequences on my life. 
     
8
8. 
My child’s Autism does not have 
much effect on my life. 
     
9
9. 
My child’s Autism strongly 
affects the way others see 
him/her. 
     
1
10. 
My child’s Autism has serious 
financial consequences. 
     
1
11. 
My child’s Autism causes 
difficulties for those who are 
close to him/her. 
     
1
12. 
There is a lot which I can do to 
control my child’s Autism 
symptoms. 
     
1
13. 
What I do can determine whether 
my child’s Autism gets better or 
worse. 
     
1
14. 
The course of my child’s Autism 
depends on me. 
     
1
15. 
Nothing I do will affect my 
child’s Autism. 
     
1
16. 
I have the power to influence my 
child’s Autism. 
     
1
17. 
My actions will have no effect on 
the outcome of my child’s 
Autism. 
     
1
18. 
My child’s Autism will improve 
in time. 
     
1
19. 
There is little that can be done to 
improve my child’s Autism. 
     
2       
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20. My child’s treatment(s) will be 
effective in curing his/her Autism. 
2
21. 
The negative effects of my child’s 
Autism can be prevented 
(avoided) by his/her treatment(s). 
     
2
22. 
My child’s treatment(s) can 
control his/her Autism. 
     
2
23. 
There is nothing which can help 
my child’s Autism. 
     
2
24. 
The symptoms of my child’s 
Autism are puzzling to me. 
     
2
25. 
My child’s Autism is a mystery to 
me. 
     
2
26. 
I don’t understand my child’s 
Autism. 
     
2
27. 
My child’s Autism doesn’t make 
sense to me. 
     
2
28. 
I have a clear picture or 
understanding of my child’s 
Autism. 
     
2
29. 
The symptoms of my child’s 
Autism change a great deal from 
day to day. 
     
30. 
 
My child’s Autism symptoms 
come and go in cycles. 
     
3
31. 
My child’s Autism is very 
unpredictable. 
     
3
32. 
My child goes through cycles in 
which the symptoms of his/her 
Autism get better and worse. 
     
3
33. 
I get depressed when I think about 
my child’s Autism. 
     
3
34. 
When I think about my child’s 
Autism I get upset. 
     
3
35. 
My child’s Autism makes me feel 
angry. 
     
3
36. 
My child’s Autism does not worry 
me. 
     
3
37. 
My child having Autism makes 
me feel anxious. 
     
3
38. 
My child having Autism makes 
me feel afraid. 
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Causes of my child’s Autism 
 
We are interested in what you consider may have been the cause of your child’s Autism. As people 
are very different, there is no correct answer for this question. We are most interested in your own 
views about the factors that caused your child’s Autism rather than what others including doctors 
or family may have suggested to you. Below is a list of possible causes for your child’s Autism. 




















1. Stress or worry      
2. Hereditary- it runs in my 
family 
     
3. A germ or virus      
4. Diet or eating habits      
5. Chance or bad luck      
6. Poor medical care in his/her 
past 
     
7. Pollution in the environment      
8. His/her own behaviour      
9. His/her mental attitude (e.g., 
thinking about his/her life 
negatively) 
     
10. Family problems or worries       
11. Overwork      
12. His/her emotional state (i.e., 
feeling down, lonely, 
anxious, empty) 
     
13. Ageing      
14. Alcohol      
15. Smoking      
16. Accident or injury      
17. His/her personality      
PARENTS’ TREATMENT SELECTION  120 
18. Altered immunity      
19. Vaccine(s)      
20. Food allergies      
21. Toxic metals in bloodstream      
22. Videos he/she watched      
23. My own behaviours/actions      
24. His/her actions in a past life      
25. Reproductive technologies 
used in his/her conception 
     
26. Illness during pregnancy      
27. Brain abnormalities      
28. Chemical imbalance      
 
In the spaces below, please list in rank-order the three most important factors that you now 
believe caused your child’s Autism.  You may use any of the items from the box above, or you may 
have additional ideas of your own.  
 
The three most important causes in my opinion: 
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Appendix E: Permission to Use AAQ-II 
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Appendix G: AAQ-II-A 
Below you will find a list of statements. Please rate how true each statement is for you by circling a 
number next to it. Use the scale below to make your choice. 
 













Always    
true 
 
1. It’s okay if I remember something unpleasant about my child 
having Autism. 
 1     2     3     4     5     6     7  
2. My painful experiences and memories of my child having Autism 
make it difficult for me to live a life that I would value. 
 1     2     3     4     5     6     7  
3. I’m afraid of my feelings toward my child having Autism. 1     2     3     4     5     6     7  
4. I worry about not being able to control my worries and feelings 
toward my child having Autism. 
1     2     3     4     5     6     7  
5. My painful memories about my child having Autism prevent me 
from living a fulfilling life. 
 1     2     3     4     5     6     7  
6. I am in control of how Autism affects my life.  1     2     3     4     5     6     7  
7. My emotions about my child having Autism cause problems in my 
life. 
 1     2     3     4     5     6     7  
8. It seems like most parents of children with Autism are handling 
their problems better than I am. 
 1     2     3     4     5     6     7  
9. Worries about my child having Autism get in the way of my 
success. 
 1     2     3     4     5     6     7  
10. My thoughts and feelings related to my child having Autism do not 
get in the way of how I want to live my life. 
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Appendix H: MCSDS-SF 
Listed below are a number of statements concerning personal attitudes and traits. Read each item 
and decide whether the statement is true or false as it pertains to you personally. 
 
Item True False 
1. I’m always willing to admit it when I make a mistake.   
2. I always try to practice what I preach.   
3. I sometimes try to get even rather than forgive and forget.   
4. I never resent being asked to return a favour.   
5. I like to gossip at times.   
6. At times I have really insisted on having things my way.   
7. I have never deliberately said something that hurt 
someone’s feelings. 
  
8. There have been occasions when I felt like smashing things.   
9. There have been occasions when I took advantage of 
someone. 
  
10. I have never been irked when people expressed ideas very 
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Appendix I: Open-Ended, Exploratory Survey Items 
1. What is your ultimate goal for your child’s treatment/intervention? 
 
2. What is the most important thing to you when selecting treatments/interventions for your 
child? 
 
3. How have your feelings about your child’s ASD changed from when he/she was first 
diagnosed to now? 
 
4. If you could describe ASD in one word, it would be _______________. 
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Appendix J: In-Depth Interview Questions 
 
1. What does ASD/Autism mean to you? 
 
 
2. What factors do you think influence how you think about Autism? 
 
 
3. What do you think it means to accept that your child has Autism? 
 
 
4. What factors do you think influence your acceptance of your child’s Autism? 
 
 
5. What were your major challenges in selecting treatments for your child with Autism? 
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LETTER OF INFORMATION AND CONSENT TO PARTICIPATE IN RESEARCH 
 
Title of study: It’s all in how you see it: Predicting parents’ treatment selection for their children     
  with Autism Spectrum Disorder 
 
You are asked to participate in a study by Brianne E. Drouillard, B.A. (Hons.), from the 
Psychology Department at the University of Windsor as part of her Master’s degree in Child 
Clinical Psychology. 
 
Dr. Marcia Gragg, Ph.D., C. Psych., is supervising the study.  If you have any questions or 
concerns, please feel free to contact Dr. Gragg at (519) 253-300, Ext. 2227. 
 
PURPOSE OF THE STUDY 
The study will examine the extent to which various factors predict parents’ treatment selection 
for their children with ASD.  This information may help professionals in guiding parents toward 
selection of evidence-based treatments for their children with ASD. 
 
PROCEDURES 
If you volunteer to participate in the study, you will be asked to provide responses to various 
questions online.  This will take approximately 20 minutes. 
 
You will also be given the opportunity to provide written responses to four open-ended questions 
concerning your goals for your child’s treatment/intervention program, your reactions to your 
child’s diagnosis of ASD, and how you think about your child’s ASD. 
 
POTENTIAL RISKS 
You might feel mild discomfort, anxiety, or sadness while answering the questions as you recall 
receiving your child’s diagnosis, think about your child having ASD, and think about how you 
selected treatments for your child.  You can access professional support by dialing 416-486-
2242 (in Canada) or 1-800-273-8255 (in the United States) should you require help with 
psychological reactions as a result of participating in this study. 
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POTENTIAL BENEFITS TO PARTICIPANTS AND/OR SOCIETY 
You may benefit directly by feeling more confident in your treatment selection decisions for 
your child with ASD and/or by confronting your feelings associated with your child’s diagnosis.  
Alternatively, you may not directly benefit from taking part in this study.  However, you will be 
providing information which may help future parents to select evidence-based interventions for 
their children with ASD.   
 
PAYMENT FOR PARTICIPATION 
To thank you for participating in this study we offer you the opportunity to enter a draw for one 
of ten $20 electronic gift cards to Amazon.com/ca.  If you are the winner of a gift card, it will be 
emailed by September 30, 2012 to the email address you provide. 
 
CONFIDENTIALITY 
Any information gathered in connection with this study and that can identify you will remain 
confidential and will not be disclosed without your permission.  The researchers will keep the 
data from this study locked in a secure location for seven years after the study is completed.  All 
data and forms will be shredded or deleted after seven years. 
 
We may wish to use your information from this study in future research studies.  Your 
information will still be confidential and identified only by an identification number. 
 
PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not.  If you volunteer to be in this study, you may 
withdraw at any time before you submit your questionnaire online without consequences of any 
kind.  You may also refuse to answer any questions you do not want to answer and remain in the 
study.  Once you have submitted your questionnaire, you will no longer be able to withdraw your 
information as there will be no way to identify and locate your specific questionnaire. 
 
If you do not wish to take part in the study once you have started, simply exit the questionnaire.  
You will be sent directly to the Draw page and you can enter the Draw even if you choose to 
withdraw from the study.  If you would like to participate, complete the questionnaire and submit 
it.  You will be sent directly to the Draw page after you have clicked submit. 
 
FEEDBACK OF THE RESULTS OF THE STUDY TO THE PARTICIPANTS 
A brief summary of the results of the research will be available by October 31, 2012 and will be 
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RIGHTS OF RESEARCH PARTICIPANTS 
You may withdraw your consent at any time and discontinue participation without penalty.  If 
you have questions regarding your rights as a research participant, please contact: Research 
Ethics Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4, (519-253-3000, Ext. 
3948), Email: ethics@uwindsor.ca 
 
SIGNATURE OF RESEARCH PARTICIPANT 
I understand the information provided for the study It’s all in how you see it: Predicting 
parents’ treatment selection for their children with Autism Spectrum Disorder as described 
in this document.  My questions have been answered to my satisfaction, and I agree to participate 
in this study. 
 
SIGNATURE OF INVESTIGATOR 
There are the terms under which I will conduct research. 
 
 
_(signature of investigator will be electronically inserted)_   ________________ 




[Click to consent]     [Click to decline] 
 
Click here to print a copy of the Letter of Information and Consent to Participate for your 
records. 
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Appendix L: Post-Study Letter of Information 
 
Title of study: It’s all in how you see it: Predicting parents’ treatment selection for their children 
with Autism Spectrum Disorders 
 
You participated in a study by Brianne E. Drouillard, B.A. (Hons.) from the Psychology Department 
at the University of Windsor.  This study is part of her Master’s degree in Child Clinical Psychology. 
 
Dr. Marcia Gragg, Ph.D., C. Psych., is supervising the study.  If you have any questions or concerns, 
please feel free to contact Dr. Gragg at mgragg@uwindsor.ca or Brianne at drouillb@uwindsor.ca. 
 
PURPOSE OF THE STUDY AND BACKGROUND INFORMATION 
 
 With the widespread use of unsupported treatments for Autism Spectrum Disorders (ASD), it 
is important to identify factors associated with selection of these treatments that may be 
possible to change. 
 
 Two of the most challenging tasks for parents of recently diagnosed children are developing 
an understanding of ASD and accepting the diagnosis of ASD. 
 
 The purpose of the present study is to identify the relations between nine aspects of parents’ 
understandings of ASD, their acceptance of their children’s ASD, and their treatment 
selection for their children. 
 
EXPECTED FINDINGS OF THE STUDY 
a) Parents with stronger beliefs in the severity of ASD and its impact on various aspects of their 
child’s functioning will be more likely to select behavioural treatments for their children; 
b) Parents with stronger beliefs in a cyclical course of ASD will be more likely to select drug-
based treatments for their children; 
c) Parents with stronger beliefs in their personal control over their child’s ASD will be less likely 
to select drug-based, diet-based, and vitamin-based treatments for their children; 
d) Parents with stronger beliefs in external causes of their child’s ASD (e.g., vaccines, pollution) 
will be more likely to select diet-based and vitamin-based treatments for their children; 
e) Parents with more negative emotional reactions to their child’s diagnosis of ASD will be less 
likely to select behavioural treatments for their children; 
f) Parents with higher levels of acceptance of their child’s ASD will be more likely to select 
supported treatments for their children; and 
g) Parents with lower levels of acceptance of their child’s ASD will be more likely to select 
unsupported treatments for their children. 
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FEEDBACK OF THE RESULTS OF THE STUDY TO THE PARTICIPANTS 
A brief summary of the results of the research will be available by February 1, 2013 and will be 
posted online at www.uwindsor.ca/autism (click on ‘Student Research’ and ‘Brianne Drouillard’). 
 
PSYCHOLOGICAL SUPPORT 
You can access professional support by contacting your family physician or by dialing 1-800-448-
1833 for the Canadian National Crisis Hotline or 1-800-273-8255 for the US National Crisis Hotline, 
should you require help with psychological reactions as a result of participating in this study. 
 
MORE INFORMATION ON SELECTING TREATMENTS FOR CHILDREN WITH ASD 
For more information on the empirical support for various treatments for children with ASD and tips 
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